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Abstract 
Peptides based on the second transmembrane segment of the glycine receptor (M2GlyR) 
were made to provide a potential therapeutic treatment for cystic fibrosis (CF) and a latent 
absorption enhancer for drug delivery. For similarity of presentation, unique synthetic peptide 
sequences have been given alpha-numeric designations. Results are presented from studies 
focusing on four peptides. 
In the first study, the contributions of synthetic peptides p1171, p1172 and p1173 to net 
transepithelial ion transport were measured as a first step toward the goal of testing whether pore 
length or electrostatics of pore lining residues will affect anion transport. Peptide p1130 exhibits 
many attributes that make it an ideal synthetic peptide for CF treatment, but has low 
permselectivity for anions. Therefore, it is used as a platform for modification. Peptide p1171 is 
doubly substituted with diaminopropionic acid at positions T13 and T17. Peptide p1172 and 
p1173 are separately one and two helical turn(s) inserted into the p1130 backbone. Apical 
exposure of MDCK monolayers to these peptides caused a rapid increase in short circuit current 
(Isc), an indicator of net ion transport. The increase in Isc caused by p1172 or p1173 was 
accompanied by increase in transepithelial electrical conductance (gte). The electrophysiological 
results suggested that these modified peptides can assemble in the apical membrane of epithelial 
cells to form functional ion-conducting pores. 
            Peptide NC-1059, which provides for ion transport across epithelial cells derived from 
many sources, was studied further to assess cellular changes that account for increased gte. NC-
1059 increased Isc, gte and enhanced permeation of dextrans in a concentration dependent 
manner. Results from previous and current studies show that NC-1059 modulated the epithelial 
paracellular pathway by altering the distribution and abundance of junctional proteins. 
Immunoblotting and immunolabeling with confocal microscopy showed that NC-1059 induces 
reorganization of actin and causes a reduction in F-actin abundance in epithelial cells. The 
distributions were changed and cellular abundances were reduced of tight junction proteins 
occludin and ZO-1 and adherens junction proteins E-cadherin and β-catenin by NC-1059. These 
effects were largely reversed in 24 hr and fully recovered in 48 hr. Therefore, NC-1059 has the 
therapeutic potential to increase the efficiency of drug delivery across barrier membranes. 
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Overview 
This thesis is focused on synthetic peptides that, when exposed to the apical aspect of 
selected epithelial cell monolayers, support anion secretion and, in some cases, modify the 
barrier integrity of the epithelial monolayers. 
The second transmembrane segment (M2) of the spinal cord glycine receptor (GlyR), 
M2GlyR, is a 23-residue helical peptide (P-A-R-V-G-L-G-I-T-T-V-L-T-M-T-T-Q-S-S-G-S-R-
A) that can form anion-selective channels (Reddy et al., 1993). The M2GlyR sequence was 
modified to generate peptides with enhanced aqueous solubility, decreased solution aggregation 
and improved chemical synthesis yields. Results from experiments employing four peptides that 
represent targeted modifications to the M2GlyR sequence are presented in Chapters 2 and 3 of 
this thesis. 
Peptide p1130 (K-K-K-K-P-A-R-V-G-L-G-I-T-T-V-L-T-M-R-T-Q-W) was expected to 
be a key sequence in the development of an alternate anion pathway(s) for the treatment of cystic 
fibrosis. However p1130 exhibits no anion-to-cation selectivity. Therefore, peptides with 
modifications in hydrogen bonding potentials of pore-lining residues, electrostatics of pore-
lining residues, pore length and pore rigidity were synthesized to determine underlying rules that 
establish anion selectivity. Results from experiments designed to test the ion channel forming 
ability of 3 derivatives of p1130, peptide p1171, p1172 and p1173, are presented in Chapter 2. 
NC-1059 (K-K-K-K-A-A-R-V-G-L-G-I-T-T-V-L-V-T-T-I-G-L-G-V-R-A-A) is a 
channel-forming peptide that reversibly increases epithelial paracellular permeability 
(Broughman et al., 2004; Somasekharan et al., 2008; Martin et al., 2009). Cell-cell junctions link 
adjacent cells and regulate the movement of solutes through the paracellular route. Thus, the 
enhanced paracellular permeability caused by exposure to NC-1059 might reflect changes in cell 
junctions. Results from experiments designed to determine the abundance and distribution of key 
junctional proteins following NC-1059 exposure are presented in Chapter 3. 
Chapter 1 provides necessary background to appreciate the lines of investigation 
described in Chapters 2 and 3. Tight junctions and adherens junctions are introduced along with 
actin cytoskeleton to provide basic concepts of cell-cell interactions. Epithelial paracellular flux 
and how it might be modulated are also introduced. The development of synthesized channel 
forming peptides is reviewed. 
 1 
 
CHAPTER 1 - INTRODUCTION 
CELL JUNCTIONS 
Multicellular organisms have structures called junctions that link adjacent cells together 
to form tissues and organs. The three general types of cell junctions are tight junctions, adhesive 
junctions and gap junctions. Adhesive junctions consist of adherens junctions and desmosomes 
at the cell-cell interface and hemidesmosomes at the cell-matrix interface. In epithelial cells, 
tight junctions, adherens junctions and desmosomes form the apical junctional complex in the 
intercellular space between adjacent cells (Fig 1.1). Among the junctional complex, tight 
junctions and adherens junctions play an important role in cell adhesion and likely contribute 
substantially to the physiological barrier separating body compartments. The architectures and 
components that constitute tight junctions and adherens junctions are discussed in detail in the 
following sections. 
 
Figure 1.1 Major types of cell junctions in epithelial cells 
Adhesive junctions (adherens junctions, desmosomes and hemidesmosomes) are located both at the cell-
cell interface and at the cell-basal lamina interface, which allows cells to function as a unit. Tight 
junctions circumscribe the apical region of epithelial cells and seal the intercellular space. Gap junctions 
are located at the basolateral region providing direct chemical and electrical communications between 
adjacent cells. The junctional complex is indicated with a circle. 
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Tight Junctions 
Tight junctions are present near the apical surface of adjacent epithelial cells and are 
known to perform two major functions: to act as a barrier and to act as a fence. ―Barrier 
function‖ means that tight junctions act as a gatekeeper to regulate the fluid and solute 
movement through the paracellular space between adjacent body compartments. ―Fence 
function‖ means that tight junctions block the lateral diffusive movement of lipids and integral 
membrane proteins in the epithelial cell membrane between the apical and basolateral surfaces of 
the cell, generating and maintaining a distinct region between adjacent epithelial cells. 
Structure of Tight Junctions 
Electron micrographs reveal the distance between adjacent epithelial cells in the non-
junction region is typically 25-35 nm. The electron micrograph in Fig 1.2A shows that, at the 
position of tight junction proteins, the spaces between adjacent cells are quite narrow, being only 
~11 nm wide, while the intercellular space is 15-20 nm in adherens junctions and desmosomes 
(Tsukita, Furuse & Itoh, 2001). This architecture suggests that the tight junction belt serves as a 
gatekeeper for paracellular permeation. Tight junctions appear as a series of regularly spaced 
cell-cell contact points when viewed as a high resolution transmission electron micrograph (Fig 
1.2B). These contact points are called ―kissing points‖ where the intercellular space is reduced to 
nearly zero. Freeze fracture replicas of tight junctions show ―kisses‖ as well. Tight junctions 
intertwine to be a continuous, anastomosing network of strands that form irregular interstrand 
compartments on the inner leaflet of the plasma membrane and the complementary vacant 
grooves on the outer leaflet (Fig 1.2C).  
 
Figure 1.2 Electron micrograph representations of tight junctions 
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A) Transmission electron micrograph of the junctional complex in mouse intestinal epithelial cells. (Mv, 
microvilli; TJ, tight junction (circled); AJ, adherens junction; DS, desmosome.) Scale bar, 200 nm.  
B) Ultrathin section view of tight junctions showing kissing points (arrowheads). Scale bar, 50 nm.  
C) Scanning electron micrograph of freeze-fracture replica of intestinal epithelial cells representing tight 
junctions on the plasma membrane (arrowheads) and on the outer leaflet (arrows). (Mv, microvilli; Ap, 
apical membrane; Bl, basolateral membrane). Scale bar, 200 nm.  
Figure as presented by (Tsukita et al., 2001).  
Transmembrane Proteins of the Tight Junction 
Tight junctions are ―multimolecular complexes‖ containing three major transmembrane 
proteins: occludin, claudin(s) and junctional adhesion molecule(s) that are described in detail in 
this section. Tight junction-associated proteins containing PSD-95/DlgA/ZO-1 homology 
domains (PDZ domains; e.g., ZO-1, ZO-2 and ZO-3), which are described in detail in a 
following section, bind to occludin and claudins and link them to the actin cytoskeleton (Fig 1.3). 
 
Figure 1.3 Schematic representation of the basic structural transmembrane components of tight 
junctions 
Occludin, claudin-X and junctional adhesion molecule-X (JAM-X) are three major types of protein 
components of tight junctions (claudin-X indicates claudin family members 1-24, JAM-X indicates JAM 
family members 1-4). Proteins of the ZO family cluster claudins and occludin to form strands and link 
them to the actin cytoskeleton. PAR3 regulates cellular polarity.  
Figure modified from (Forster et al., 2008). 
 
Occludin 
Occludin was identified as the first integral membrane protein localized at tight junctions 
in chick liver (Furuse et al., 1993) and was later shown to be present in T84 cells (Ando-
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Akatsuka et al., 1996), a cell line derived from human colon (Dharmsathaphorn et al., 1984). 
Occludin has 2 isoforms arising from alternative splicing of one transcript with an identical 
tissue distribution (Muresan, Paul & Goodenough, 2000). Occludin is a ~65 kDa tetraspan 
membrane protein that has two extracellular loops (~47 residues) separated by a short cytosolic 
loop, along with a short amino-terminal cytosolic domain and a long carboxyl-terminal cytosolic 
domain (Fig 1.4). Both extracellular loops are required for cell-cell adhesion and to constitute the 
epithelial barrier while the carboxyl-terminal domain is required for interaction with ZO-1 and 
targeting at tight junctions (Mitic & Anderson, 1998).  
 
Figure 1.4 Membrane topology of tight junction proteins 
Occludin is a tetraspan protein with two extracellular loops, a short cytosolic loop and a long carboxyl-
terminal cytosolic domain. Claudin-X also has four transmembrane domains but has a shorter cytoplasmic 
tail than occludin. JAM-X has two folded IgG-like extracellular domains with disulfide bonds (claudin-X 
indicates claudin family members 1-24, JAM-X indicates JAM family members 1-4). 
Figure modified from (Schneeberger & Lynch, 2004). 
 
Anti-occludin antibodies labeled tight junction strands indicated that occludin directly 
integrates into tight junction strands (Saitou et al., 1997). However, the physiological function(s) 
of occludin at tight junctions is not clearly understood. Transepithelial electrical resistance (Rte) 
and paracellular permeability are parameters to study the barrier function of tight junctions. 
Epithelia with higher Rte and lower paracellular permeability have tight junctions that prevent 
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movement through the paracellular space of adjacent cells at a larger extent. Selective removal of 
occludin by exposure to synthetic peptide OCC2, corresponding to the second extracellular loop 
of chick occludin 
(GVDNPQAQMSSGYYYSPLLAMCSQAYGSTYLNYQYIYHYCTVDPQE), in culture 
medium decreased Rte and increased paracellular permeability suggesting that occludin is 
involved in the barrier function of tight junctions (Wong & Gumbiner, 1997). Overexpression of 
occludin increased Rte in MDCK cells but paradoxically increased paracellular flux of 4 kD 
FITC-dextran (Balda et al., 1991; McCarthy et al., 1996). Furthermore, occludin-deficient 
embryonic stem cells generated polarized epithelial cells with no observable differences in tight 
junction strands when compared to wild-type epithelial cells as shown by immunofluorescence 
microscopy and transmission electron microscopy (Saitou et al., 1998). Occludin-deficient mice 
exhibited no global epithelial defect. Rather, the phenotype was characterized by postnatal 
growth retardation, chronic inflammation and hyperplasia of the gastric epithelium, calcification 
in the brain and abnormalities in the testis, salivary gland and bone (Saitou et al., 2000). 
Therefore, although the fundamental role of occludin is not yet defined, occludin is involved in 
tight junction strands and contributes to barrier function of tight junctions. 
 
Claudins 
Claudins constitute a multigene family of at least 24 isoforms in mammals with 
molecular masses ranging from 20 kDa to 27 kDa. Like occludin, claudins are four 
transmembrane domain proteins, although they exhibit no sequence similarity to occludin. 
Claudins have a large (~52 residues) extracellular loop and a small (~25 residues) extracellular 
loop separated by an intercellular loop along with a very short amino-terminal cytoplasmic 
sequence (~7 residues) and a carboxyl-terminal cytoplasmic sequence (Fig 1.4). The C-terminal 
ends differ in length between isoforms (21-63 residues), but all except claudin-12 end in YV, a 
sequence that binds to the PDZ domains of tight junction-associated proteins such as MAGUKs, 
ZO-1, ZO-2, ZO-3 (Itoh et al., 1999), MUPP1 (Hamazaki et al., 2002; Roh et al., 2002) and 
PATJ (Roh et al., 2002). Inducible expression of claudin-1 that lacks its C-terminal YV residues 
formed aberrant tight junction strands with no associated ZO-1, which suggests that the C-
terminus plays a fundamental role in the interaction between claudins and tight junction-
associated proteins (McCarthy et al., 2000).  
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Claudin isoform expression is organ and tissue specific (Table 1.1). Moreover, two or 
more distinct claudins are coexpressed in most cell types in various combinations and distinct 
claudins are coincorporated into individual tight junction strands (Furuse, Sasaki & Tsukita, 
1999). The Rte difference between MDCK І and MDCK II cells might be due to the expression of 
different claudin isoforms. MDCK І cells express primarily claudin-1 and claudin-4 whereas 
MDCK II cells, which express claudin-2 as well as claudin-1 and claudin-4, have a 30–60 fold 
lower Rte. Transfecting claudin-2 into MDCK І cells resulted in reduced Rte values (Tsukita et al., 
2001). 
Table 1.1 Claudin gene families 
Claudins
*
 Expression
#
 
Heart Brain Lung Liver Kidney Testis Other 
Claudin-1 + + + + + +  
Claudin-2 - - - + + -  
Claudin-3 - - + + + ±  
Claudin-4 - - + - + -  
Claudin-5 + + + + + + Endothelial cells 
Claudin-6 - - - - - - Embryonic tissues 
Claudin-7 - - + - + ±  
Claudin-8 - - + ± + ±  
Claudin-10 ND ND ND ND ND ND  
Claudin-11 - + - - - + Oligodendrocytes, Sertoli cells 
Claudin-14 - - - + + ND Hair cells in the Corti organ 
Claudin-16 - - - - + ND Thick ascending limb of Henle 
*
 Claudin-9,-12,-13, -15 and 17-24 have not been characterized well. 
 
# 
Detected by northern blotting.  
+, detectable expression; -, expression not detected; ±, expression variably detectable. 
ND, not determined. 
Table as presented by (Tsukita et al., 2001). 
 
Claudins play important roles in the formation of tight junction fibers and in regulating 
paracellular selectivity to ions. Immuno-replica electron microscopy revealed that claudins 
constitute the backbone of tight-junction strands. Tight junction strands can be reconstituted by 
introducing a single gene encoding claudin-1 or -2 into mouse L-cells, a fibroblastic cell line, 
that otherwise lacks tight junctions (Furuse et al., 1998). Overexpression or knockdown of 
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selected claudins in epithelial cell lines shows that claudin-1, -4, -5, -8, -11 or -14 expression 
increases Rte by decreasing cation permeability while claudin-2, -10b or -15 expression decreases 
Rte by acting as cation-selective pores (Angelow, Ahlstrom & Yu, 2008).  
Claudins also effects paracellular charge selectivity. Paracellular pathway, discussed in 
details in the following section, is the route between cells. Solutes travel through junctional 
proteins in the paracellular pathway to pass across epithelial layers. The first extracellular 
domain of claudin-15 has 3 acidic residues. When those acidic amino acids are replaced with 
basic residues, the dilution potential on MDCK monolayers dropped from 7.6 ± 0.6 to -7.1 ± 0.7 
mV, indicating that the ratio of PNa to PCl decreased after the mutation of claudin-15 (Colegio et 
al., 2002). It suggested that claudin-15 is important in cation-selective permeation. Claudin-4 has 
a positively charged residue in the first extracellular domain. When claudin-4 is expressed in 
MDCK monolayers, dilution potential decreased from 8.4 ± 0.4 to 4.2 ± 0.9 mV, which 
suggested that Na
+
 permeability decreased. When this positively charged residue is mutated to a 
negatively charged residue, Na
+
 permeability increased (Colegio et al., 2002). Experiments had 
shown that not only claudin-4, but also claudin-10a (Van Itallie & Anderson, 2006) and possibly 
claudin-7 (Hou et al., 2006) may provide for anion-selective permeation. Therefore, claudins 
create charge-selective channels in the paracellular space (Van Itallie & Anderson, 2004). 
Claudins not only form charge and ion selective pores, but also influence the formation of 
size-selective paracellular pores that control the movement of noncharged solutes. 
Overexpression of claudin-2 increased the apparent permeability (Papp) for polyethylene glycols 
(PEGs) that can traverse a pore (< 4 Å) but did not change the permeability for larger PEGs. That 
is, expression of claudin-2 increases the number of small pores. However, the overexpression of 
claudin-4, -14 and -18 had no effect on pore number or pore size but significantly increased Rte 
(Van Itallie et al., 2008). 
  
Junction-associated adhesion molecules (JAMs) 
Junctional adhesion molecules (JAMs; ~40 kDa) are members of the immunoglobulin 
(Ig) superfamily that localize to the tight junctions of both epithelial and endothelial cells. JAMs 
have a single transmembrane domain, two folded immunoglobulin-like domains in the 
extracellular space with intrachain disulfide bonds and a carboxyl-terminal cytoplasmic sequence 
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that ends with a PDZ-binding motif, which enables it to interact with structural and signaling 
proteins (Fig 1.4). JAMs have at least 4 isoforms, among which JAM-1 is best described. 
Both confocal and immunoelectron microscopy data showed that JAMs are concentrated 
at the apical region of intercellular junctions (Malergue et al., 1998). CHO cells (Malergue et al., 
1998) and L cells (Itoh et al., 2001) expressing JAM did not form tight junction-like strands, but 
formed planar aggregates through their lateral self-association. JAM-1 forms homophilic 
adhesion between adjacent cells and directly associates with ZO-1, PAR-3 (Itoh et al., 2001), 
occludin and cingulin (Bazzoni et al., 2000). Thus, JAM is involved in cell-cell adhesion 
assembly of epithelial cells (Forster et al., 2008). 
 
Tight junction-associated proteins 
Peripheral membrane proteins that have PDZ domains, such as ZO-1, ZO-2 and ZO-3, 
play curial roles in the formation of tight junctions or in the intracellular signaling originating 
from tight junctions (Adachi et al., 2006). PDZ domains are protein-protein interaction domains 
first described in the proteins PSD-95, DLG and ZO-1 (Tsukita et al., 2001). ZO-1 (zonula 
occludens-1, ~220 kDa), ZO-2 (~160 kDa) and ZO-3 (~130 kDa) have sequences that are similar 
to one another and all of them have three PDZ domains, one src homology region 3 (SH3) 
domain and one guanylate kinase-like (GUK) domain in their NH2 termini, for which reason they 
are called MAGUKs (for membrane-associated guanylate kinase proteins; Fig 1.5) (Adachi et al., 
2006; Furuse et al., 1994; Kniesel & Wolburg, 2000). 
 
Figure 1.5 Schematic representation of ZO-1, ZO-2 and ZO-3 
The PDZ domains responsible for intermolecular association are indicated by arrowheads. (ZONAB, ZO-
1-associated nucleic acid binding protein; AF-6, ALL-1 fusion partner from chromosome 6; GUK, 
guanylate-kinase-like domain; SH3, src homology region 3; SAF-B, scaffold attachment factor-B). 
Figure modified from (Schneeberger & Lynch, 2004). 
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ZO-1 was the first identified tight junction-associated protein and remains the best 
described (Stevenson et al., 1986). ZO-1 links to claudins through its PDZ1 domain, to ZO-2, 
ZO-3 and a gap junction protein, connexin 43, through its PDZ-2 domain, to JAM-1 through its 
PDZ-3 domain, to ZO-1 nucleic acid binding protein (ZONAB) through its SH3 domain, to 
occludin through its GUK domain, to Ras target AF-6 (Yamamoto et al., 1997), cingulin 
(Cordenonsi et al., 1999) and most important, the actin cytoskeleton through its proline-rich C 
terminus (Tsukita et al., 2001). A knockout of ZO-1 in mouse epithelial cells resulted in marked 
retardation in the formation of tight junctions when the epithelial polarization was initiated by 
switching from low Ca
2+
 media to normal Ca
2+ 
media (Umeda et al., 2004). This outcome 
suggested that no tight junctions are formed without tight junction-associated proteins. However, 
in non-epithelial cells lacking tight junctions such as cardiac muscle cells or in epithelial cells 
lacking well developed tight junctions such as hepatocytes, ZO-1 was also reported to be 
enriched in adherens junctions (Kniesel & Wolburg, 2000). Since PDZ-containing proteins have 
diverse interactions with tight junction proteins and serve as anchors to the actin cytoskeleton, 
they are crucial in tight junctions. 
 
Adherens Junctions 
Adherens junctions are multiprotein complexes that mediate cell-cell adhesion. In 
polarized epithelial cells, adherens junctions appear as zipper-like zones that circumscribe entire 
cells and thus are also called ―the adhesion belt‖. Adherens junctions consist of two basic 
adhesive units: the nectin-afadin adhesion complex and the cadherin-catenin ‗core‘ adhesion 
complex, which is studied more widely (Fig 1.6). Nectins and nectin-like molecules are members 
of the immunoglobulin-like superfamily that participates in calcium-independent cell adhesion. 
Nectins undergo both trans-homophilic and trans-heterophilic interactions, interact with an actin-
binding protein AF6/afadin and play roles in the formation of cell-cell junctions (Ebnet, 2008).  
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Figure 1.6 Schematic representations of the basic structural components of the adherens junctions 
Shown are the cadherin-catenin complex and the nectin-afadin complex.  
Figure modified from (Ogita, Ikeda & Takai, 2008). 
 
Cadherin-catenin complex 
Cadherins constitute a group of calcium-dependent adhesive glycoproteins present in the 
plasma membranes of most animal cells. Upon calcium binding, the extracellular domains of 
cadherins rigidifies to form a rod-like ectodomain that allows them to mediate cell-cell adhesion 
(Tai, Kim & Schuman, 2008).  
More than 100 cadherin family members have been described and divided into 7 
subfamilies varying in numbers of structurally similar subunits (called repeats) and in the 
structure of their cytosolic ends. The adherens junctions contain classical Type І and Type II 
cadherins. Among those cadherins in adherens junctions, E-cadherins, a ―classical‖ Type І 
cadherin is best characterized. E-cadherins associate as homodimers in the plasma membranes 
and interact with homodimers in the neighboring cell through their extracellular domains (Resink 
et al., 2009). Adhesion is conferred by the interaction of  the cytoplasmic carboxyl-terminal 
regions of E-cadherins to β-catenin, which further binds to α-catenins to link E-cadherins to actin 
filaments (Rudini & Dejana, 2008). β-catenin is a central player for full adhesive function due to 
its bridge function. Phosphorylation of β-catenin significantly reduces the affinity of cadherin for 
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β-catenin and results in disassembly of cadherin-containing complexes and affects cell-cell 
adhesion (Gloushankova, 2008; Roura et al., 1999). 
Cell junctions provide important adhesive contacts between adjacent cells. Although tight 
junctions and adherens junctions contain different transmembrane proteins, they are both 
anchored to actin filaments, which are key components of the cytoskeleton. The efficient 
formation and maintenance of cell adhesion also requires the involvement of the actin 
cytoskeleton (Miyoshi & Takai, 2008). Therefore, actin filaments are discussed in the next 
section.  
 
Actin Cytoskeleton 
The equilibrium between G-actin and F-actin 
Actin is an abundant protein with a molecular mass of ~42 kDa, which folds into a U-
shape with a central cavity that binds ATP or ADP. Actin exists in two forms: a globular 
monomeric form (G-actin) and as a polymerized microfilament (filamentous F-actin). G-actin 
can polymerize reversibly into several different and distinct polymers. Actin polymerization 
follows a nucleation-elongation scheme that ultimately forms two parallel helical F-actin strands 
with roughly 13.5 actin monomers per turn. To start actin filament growth, the ADP bound G-
actin is nucleotide exchanged to its ATP-bound form (Fig 1.7). Those ATP-bound G-actin 
monomers form dimmers and then trimers, which act as ―nuclei‖ for consequent filament 
growth. Nucleation of ATP-bound G-actin monomers is unfavorable since these ―nucleus‖ are 
unstable. However, elongation of actin filaments is favorable and once the elongation step is 
started, actin filaments grow rapidly (Sept & McCammon, 2001). The growing end is called the 
plus (+) end while the non-growing end is called the minus (-) end. Once the actin filament is 
formed, the ATP bound to G-actin is hydrolyzed slowly to ADP and actin filaments 
depolymerize from the minus end. 
 
Figure 1.7 Model of microfilament dynamic equilibrium 
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ATP-bound G-actin monomers polymerize to form long filamentous polymers F-actin. Aged F-actin 
hydrolyzes to ADP-bound G-actin and depolymerize. Actin recycles the processes of polymerization and 
depolymerization. 
 
G-actin and F-actin will exist in a dynamic equilibrium. Specific proteins and plasma 
membrane lipids can affect polymer dynamics at the ends of microfilaments to enhance or reduce 
the proportion of F-actin. Inositol phospholipids, the actin-related protein (Arp) 2/3 complex and 
the small regulatory GTP-binding proteins known as Rac, Rho, and Cdc42 are examples of 
cellular components that affect the G-actin to F-actin ratio. Some drugs have similar effects on 
actin. Cytochalasins, a group of fungal metabolites, bind to the plus ends of actin filament and 
prevent addition of G-actin subunits to existing polymerized microfilaments. As G-actin subunits 
are lost from the minus ends, actin filaments disappear (Cooper, 1987).  Latrunculin A, another 
actin depolymerization reagent, binds to actin monomers and prevents their addition to the plus 
end of microfilaments (Ayscough, 2005). In contrast, Phalloidin functions as an actin stabilizing 
reagent by binding to actin filaments, preventing depolymerization and finally shifting the 
equilibrium between filaments and monomers toward F-actin (Cooper, 1987). 
Functions of Actin Microfilaments 
Actin microfilaments play multiple roles in promoting cell movement, developing and 
maintaining cell shape, establishing intercellular adhesion and supporting signal transduction. 
The extracellular seal produced by tight junctions and adherens junctions is dependent on actin 
microfilaments (Miyoshi & Takai, 2008). Adding the actin-disrupting drug cytochalsin D or 
latrunculin A to epithelial cells resulted in a significant decrease in Rte (Stevenson & Begg, 1994) 
as well as redistribution of tight junction proteins (Madara, Barenberg & Carlson, 1986). 
Meanwhile, changes in cell permeability and in tight junctions are often concomitant with 
changes in actin filament organization. For example, cytokines such as the interleukins (ILs), 
tumor necrosis factor alpha (TNFα) and interferon gamma (IFNγ), not only reduce expression of 
tight junction proteins but also promote reorganization of the actin cytoskeleton (Forster et al., 
2008). Rho protein causes a dramatic increase in tight junction permeability with concomitant 
actin reorganization as well (Jou, Schneeberger & Nelson, 1998; Nusrat et al., 1995).  
The outcomes, that altering the actin cytoskeleton destabilizes the junctional complex and 
vice versa, suggested that cell junctions physically link to the actin cytoskeleton. In epithelial 
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cells, actin cytoskeletons, together with tight junctions and adherens junctions, divide the plasma 
membrane into apical and basolateral domains and, thus, contribute to epithelial cell polarity 
(Miyoshi & Takai, 2008). These structures are also involved when solutes cross epithelial cell 
monolayers through the paracellular space as discussed in detail in the next section. 
 
 
Epithelial Paracellular Flux 
Transcellular pathway and paracellular pathway 
Transepithelial solute movement occurs through both transcellular and paracellular 
pathways (Fig 1.8). In the transcellular pathway, substances travel across the apical membrane, 
the cytoplasm and basolateral membrane in a directional, energy dependent way controlled by 
specific membrane transporters and channels (Anderson, 2001). In the paracellular pathway, 
solutes pass through tight junctions and adherens junctions in the extracellular space between 
adjacent cells. The paracellular pathway allows for the passive movement of material down 
electrochemical gradients that are externally imposed or created by transcellular mechanisms 
(Van Itallie & Anderson, 2006). 
 
Figure 1.8 Schematic diagram of epithelial cell transport pathways 
There are two pathways through which solutes cross epithelial and endothelial cellular sheets: the 
transcellular route and the paracellular route. Rs, paracellular resistance; Rc, transcellular resistance; Rte, 
transepithelial resistance.  
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The paracellular pathway can be studied by measuring Rte and the permeability to labeled 
tracer molecules (Matter & Balda, 2003). The measured Rte is the parallel connection of the 
paracellular resistance Rs and the transcellular resistance Rc (Rte= (Rc × Rs) / (Rc + Rs)). In 
commonly studied epithelia, the paracellular resistance is much less than the transcellular 
resistance. For example, in small intestine, gall bladder, or cell lines such as MDCK and CaCo-2, 
Rte is ~60-250 Ω cm
2
 while the Rc is on the order of 1,000-10,000 Ω cm
2 
(Madara, 1989). Thus, 
Rte largely reflects the paracellular resistance and the paracellular pathway is the major site for 
transepithelial permeation (Blikslager et al., 2007). Since tight junctions are often rate limiting in 
solute movement through the paracellular pathway, alternations in Rte  are often used as an index 
of tight junction permeability (Madara, 1989). 
Paracellular permeability can be assessed by quantifying the movement of labeled tracer 
molecules. Tracer molecules of various sizes, such as mannitol, inulin and dextran labeled with 
radioisotopes or fluorescent tags are used. For example, dextran can only permeate the 
paracellular route. Therefore, permeation by selected sizes of dextran provides evidence 
regarding the ―openness‖ and size exclusion for this pathway. Compared with measurement of 
Rte, tracer molecule permeability detection assay can be taken over a longer period of time but 
allows the quantification of slow diffusion and size selectivity of the paracellular barrier (Kapus 
& Szaszi, 2006). 
 
Modulation of paracellular pathway and drug delivery 
Therapeutic agents typically cross epithelial and endothelial cell layers to reach their 
targets. Lipophilic solutes can cross biological membranes by simple diffusion and can be 
selectively transported by channel, pumps and carriers present in plasma membranes (Gonzalez-
Mariscal, Hernandez & Vega, 2008). For hydrophilic drugs that cannot passively cross biological 
membranes, the paracellular pathway can be a major route for absorption (Salama, Eddington & 
Fasano, 2006). Tight junctions, which exist in both epithelial and endothelial cells, strictly 
regulate the movement of solutes through the paracellular route. Therefore, strategies to open 
tight junctions were designed to modulate the bioavailability of hydrophilic drugs. 
One method to enhance paracellular solute passage is to uncouple the protein-protein 
interactions in the intercellular space of tight junctions. Wong and Gumbiner synthesized a 
peptide corresponding to the second loop of chicken occluding. The synthetic peptide competed 
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with the interactions of occludin between adjacent cells, reducing Rte from ~6000 Ω cm
2
 to ~900 
Ω cm2 and increasing the flux of paracellular tracers including mannitol (hydrodynamic radius ~ 
4 angstrom), inulin (hydrodynamic radius ~10-14 angstrom) and dextran 3,000 by ~10 fold 
across A6 cell monolayers, a cell line derived from Xenopus kidney epithelium (Liang et al., 
2000; Nusrat et al., 2005; Wong & Gumbiner, 1997). Therefore, by changing peptide 
corresponding to external portion of tight junction proteins, paracellular permeability can be 
enhanced. 
Specific degradation of mRNA coding for individual tight junction proteins can also 
affect the paracellular movement. Yu silenced the expression of occludin using siRNA in MDCK 
cells. Occludin expression was reduced by 96-98% and the epithelial cells had a 50% to 75% 
lower maximum Rte compared with vehicle (Yu et al., 2005). siRNA knock down of claudin 4 
resulted in a significant Rte decrease as well as dextran permeability increase in respiratory cells 
(Gonzalez-Mariscal, Nava & Hernandez, 2005). The silenced expression of tight junction 
proteins reduced Rte and increased paracellular permeability. 
Another common method to open the paracellular route is the use of toxins and proteins 
derived from microorganisms. Bacterial toxins, such as Clostridium difficile enterotoxins, 
Esoherichia coli enterotoxins, Vibrio cholerae enterotoxin (zonula occludens toxin) are capable 
of rearranging the actin cytoskeleton, affecting specific tight junction proteins, and therefore 
increasing the paracellular permeability (Fasano, 2000; Salama et al., 2006).  Among these, the 
role of Clostridium difficile is probably best known. The enterotoxin (toxin A) and the cytotoxin 
(toxin B) made the GTP-binding protein Rho inactive and degraded F-actin (Just et al., 1994). 
Therefore, purified Toxin A from Clostridium difficile at a concentration of as low as 7 × 10
-1
 
µg/ml (3 ×10
-9
 M) decreased the Rte across T84 cell monolayers to 20% of its original value 
(Hecht et al., 1988). Thus, through a rearrangement of the actin cytoskeleton, bacterial toxins can 
affect paracellular pathway. 
Opening the paracellular pathway by changing the molecular constituents of tight 
junctions can be used as an effective method for hydrophilic drug delivery. However, opening of 
paracellular pathway might also increase the risk of introducing organisms or toxins that are 
typically confined to the intestinal lumen. Therefore, identifying strategies to open the 
paracellular route while minimizing the risk for movement of potentially toxic luminal 
components is a high priority. 
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Synthetic Peptides 
Synthesized peptides to enhance paracellular permeability 
The glycine receptor (GlyR), GABAA receptor (GABAAR), 5-HT3 receptor and nicotinic 
acetylcholine receptor (nAChR) belong to a superfamily of ligand-gated channels formed by a 
pentameric arrangement of subunits having four predicted transmembrane segments, M1-M4, 
among which, the M2 segments line a hydrophilic ion conductive pathway. The M2 segment of 
the glycine receptor, M2GlyR, a 23-residue helical peptide with a sequence of P-A-R-V-G-L-G-
I-T-T-V-L-T-M-T-T-Q-S-S-G-S-R-A, was synthesized by members of this laboratory as a first 
step in developing synthetic peptides that could form ion selective channels (Reddy et al., 1993). 
To enhance the aqueous solubility of the M2GlyR sequence, lysine residues were added 
systematically to either the C-terminus (CK4-M2GlyR, P-A-R-V-G-L-G-I-T-T-V-L-T-M-T-T-Q-
S-S-G-S-R-A-K-K-K-K) or the N-terminus (NK4-M2GlyR, K-K-K-K-P-A-R-V-G-L-G-I-T-T-V-
L-T-M-T-T-Q-S-S-G-S-R-A) (Tomich et al., 1998). Initially the CK4-M2GlyR sequence was 
tested using MDCK monolayers, a cell line derived from canine kidney (Broughman et al., 2001; 
Wallace et al., 1997b). When exposed to the apical membrane of MDCK cells, CK4-M2GlyR 
appeared to generate chloride-selective channels in the apical membrane and to induce sustained 
transepithelial secretion of Cl
-
 and fluid. NMR and molecular modeling results showed that 
lysine residues in CK4-M2GlyR form a C-terminus cap structure by folding back to form 
hydrogen bonds with backbone carbonyl groups and hydroxyl side chains of residues in the 
helical segment of the peptide, thus impairing both channel conductance and membrane insertion 
(Broughman et al., 2002a). Similar analysis of NK4-M2GlyR did not reveal a capping structure 
but instead showed a much higher channel forming activity. Since ―peptide-based channel 
replacement therapy‖ requires a channel-forming peptide with substantial aqueous solubility and 
little solution aggregation, a series of C- and N- terminus oligo-lysyl-modified peptides with 
amino acid residues deleted from the end opposite the lysine tail were synthesized and tested 
(Broughman et al., 2002b). The results show that a region of NK4-M2GlyR near the C terminus 
promotes aqueous aggregation and that removal of 11 amino acids from the C-terminal end 
eliminated aggregation. The N-terminus contributes to helical bundle formation, which is 
necessary for channel activity, and removal of 5 amino acids from the N-terminus decreased 
significantly the channel-forming ability.  
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A palindromic sequence was designed based on the bundle-forming, non-aggregating, 
NH4-terminal portion (underlined) of M2GlyR positioned around a central leucine (K-K-K-K-P-
A-R-V-G-L-G-I-T-T-V-L-V-T-T-I-G-L-G-V-R-A-P). In order to improve the chemical synthesis 
yields, the C- and N-terminal proline residues were replaced with alanines. The resulting 
palindromic sequence (K-K-K-K-A-A-R-V-G-L-G-I-T-T-V-L-V-T-T-I-G-L-G-V-R-A-A), 
designated NC-1059, was synthesized and analyzed for solubility, aggregation and channel-
forming activity (Broughman et al., 2004). NC-1059 reversibly increases Isc, gte and dextran 
permeation in a concentration dependent manner when exposed to epithelial cells (Broughman et 
al., 2004; Somasekharan et al., 2008). 
 
Peptide characteristics that potentially enhance anion selectivity 
One final purpose in studying variants of M2GlyR is to synthesize an ideal sequence, 
which exhibits aqueous solubility, little self-association in aqueous solutions, low aqueous 
concentration required to achieve ion channel formation in cell membranes, and high anion to 
cation selectivity of the resulting channels. In those M2GlyR derived peptides, p1130 (K-K-K-K-
P-A-R-V-G-L-G-I-T-T-V-L-T-M-R-T-Q-W) exhibits enhanced aqueous solubility as a monomer 
and undergoes supramolecular assembly in the biological membranes at low aqueous 
concentration. However, the pores formed by p1130 show no anion selectivity. Therefore, 
peptides based on the p1130 amino acid sequence, with alterations in: 1) hydrogen bonding 
potentials of pore lining residues; 2) electrostatics of pore lining residues; 3) pore length; and 4) 
pore rigidity, were synthesized and tested in an attempt to determine which parameter(s) would 
affect anion selectivity. 
Peptide p1171 (K-K-K-K-P-A-R-V-G-L-G-I-Dap-T-V-L-Dap-M-R-T-Q-W) is a peptide 
that contains the unusual amino acid diaminopropionic acid (L-Dap) at positions 13 and 17 in the 
p1130 sequence. It was synthesized to test whether changes in pore residue electrostatics by 
adding two positively charged amino acids would affect ion channel-forming function and anion 
selectivity. Peptide p1172 (K-K-K-K-P-A-R-V-G-L-G-I-L-T-G-I-T-T-V-L-T-M-R-T-Q-W) is a 
peptide containing one more internal helical turn than p1130 while p1173 (K-K-K-K-P-A-R-V-
G-L-G-L-T-G-I-L-T-G-I-T-T-V-L-T-M-R-T-Q-W) is a peptide containing two additional 
internal helical turns than p1130. A structural model of peptide p1130 made by Jianhan Chen 
indicates an apparent thinning of membrane near the ion channel. Peptides p1172 and p1173 
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with longer membrane spanning lengths should induce less membrane thinning. Therefore, they 
were synthesized to test whether eliminating membrane thinning by increasing pore length would 
affect ion channel-forming function or anion selectivity. 
Other sequence modifications based on p1130 are being studied to find an ideal channel-
forming sequence with high anion selectivity. These studies are in progress and are outside the 
scope of current thesis. 
 
Goals of Study  
In this study, MECK cells were used as an experimental model to test for the channel-
forming functions of novel peptides whose sequence is based on the amino acid sequence of 
p1130, with the final purpose of identifying compounds that can enhance apical Cl
-
 conductance 
and serve as a substitute for endogenous Cl
-
 channels that are defective in cystic fibrosis 
(Chapter 2). 
Chapter 3 focuses on the effects of NC-1059 on MDCK cell monolayers. The cellular 
expressions and distributions of tight junction proteins, adherens junction proteins and actin 
cytoskeleton were tested to attain a better understanding of how NC-1059 increased epithelial 
paracellular permeability. Recovery of expression and distribution of junction protein and actin 
as well as Rte across MDCK monolayers after 24 and 48 hours NC-1059 treatment were also 
studied. The low cytotoxicity of NC-1059 indicates that NC-1059 can be used as an absorption 
enhancer to increase the efficiency of drug delivery across barrier membranes. 
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CHAPTER 2 - p1130, A Synthetic Channel-forming Peptide and 
Derivatives Modulate Transepithelial Electrical Conductance across 
MDCK cell monolayers 
Abstract 
The goal of this study is to test the biological activities of p1130 derivates p1171, p1172 
and p1173. Ussing chamber data suggested that apical exposure to p1171 increased short circuit 
current but did not influence transepithelial electrical conductance. The treatment of p1172 and 
p1173 increased short circuit current as well as conductance. These outcomes indicate that these 
p1130 derivates have channel-forming potentials across epithelial monolayers. 
 
 
Introduction 
M2GlyR (P-A-R-V-G-L-G-I-T-T-V-L-T-M-T-T-Q-S-S-G-S-R-A) is a synthetic peptide 
based on the second transmembrane of the GlyR α1 subunit. Existing evidences suggest that 
when exposed to the apical aspect of epithelial cells, M2GlyR incorporates with the cell 
membrane and undergoes supramolecular assembly to form anion-selective channels. However, 
M2GlyR has a low aqueous solubility as well as a propensity to aggregate in aqueous 
environment. These shortcomings limit the clinical application of M2GlyR as a potential 
treatment for cystic fibrosis. Therefore, more than 200 M2GlyR derived peptides were 
synthesized to optimize the peptide for clinical purpose by achieving higher aqueous solubility, 
lower solution associations as well as high anion selectivity.  
Peptide p1130 (K-K-K-K-P-A-R-V-G-L-G-I-T-T-V-L-T-M-R-T-Q-W) is unique among 
the sequences derived from M2GlyR in that it appears to exhibit high aggregate conductivity, but 
virtually no anion to cation selectivity. Therefore, it is used as a platform for additional amino 
acid substitutions aimed at restoring anion selectivity. Modifications have been introduced to 
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alter pore residue electrostatics and pore length resulting in 3 sequences that provide the basis for 
outcomes presented in this chapter.  
Peptide p1171 (p1130-T13Dap, T17Dap: K-K-K-K-P-A-R-V-G-L-G-I-Dap-T-V-L-Dap-
M-R-T-Q-W), a peptide in which threonines (T) in p1130 are substituted by the 
diaminopropionic acid (L-Dap) at positions T13 and T17, was synthesized to study how 
electrostatics of pore lining residues affect assembly in cell membranes. Dap is a positively 
charged amino acid while T is polar yet uncharged. The introduction of two positive charges into 
the middle of a transmembrane sequence could prevent or reduce membrane insertion of this 
sequence. Before other Bis-Dap sequences are prepared it is important to determine whether the 
sequence produced a functional ion channel.  
Two other sequences, p1172 (p1130-  ILTG -p26: K-K-K-K-P-A-R-V-G-L-G-I-L-T-G-
I-T-T-V-L-T-M-R-T-Q-W) and p1173 (p1130-  LTGILTG -p29: K-K-K-K-P-A-R-V-G-L-G-
L-T-G-I-L-T-G-I-T-T-V-L-T-M-R-T-Q-W), were synthesized to test for the effect of pore length 
on transepithelial ion flux. Modeling studies by Jianhan Chen suggested that the p1130 sequence 
caused a thinning of the lipid bilayer while these two peptides addressed the issue of pore length 
by adding one and two internal helical turns to p1130, respectively.  Therefore, by inserting these 
helical turns in the positions indicated, the registry of the pore lining residues was maintained 
while lengthening the transmembrane segment. In this study the ability of these new sequences 
to insert into the membrane and then form functioning channel assemblies was tested. 
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Methods 
Peptide Synthesis: All peptides were synthesized using solid-phase synthesis employing 
an automated base-labile 9-fluorenylmethyloxycarbonyl (Fmoc) strategy as described (Wallace 
et al., 1997b). Prepared peptides were purified to homogeneity by reverse-phase HPLC and 
analyzed by matrix-assisted laser desorption time of flight mass spectroscopy (Broughman et al., 
2002a). The sequences of the peptides tested in this experiment are as follows: 
 
p1171: K-K-K-K-P-A-R-V-G-L-G-I-Dap-T-V-L-Dap-M-R-T-Q-W  
p1172: K-K-K-K-P-A-R-V-G-L-G-I-L-T-G-I-T-T-V-L-T-M-R-T-Q-W  
p1173: K-K-K-K-P-A-R-V-G-L-G-L-T-G-I-L-T-G-I-T-T-V-L-T-M-R-T-Q-W 
 
Chemicals: 1-EBIO (1-ethyl-2-benzimidazolinone; Acros, Pittsburgh, PA) was prepared 
as 1 M stock solution in dimethyl sulfoxide. Forskolin (Coleus forskohlii; Calbiochem, La Jolla, 
CA) was prepared as 10 mM stock in ethanol. Peptide stock solutions of 5 mM, calculated based 
on the theoretical molecular weight of synthetic peptides, were prepared in deionized water just 
prior to use. Unless otherwise noted, all other reagents were purchased from Sigma Chemical 
(St. Louis, MO). 
Cell culture: MDCK (Madin-Darby canine kidney) cells were obtained from Dr. 
Lawrence Sullivan (University of Kansas Medical Center, Kansas City, KS). The culture 
medium was a 1:1 mixture of Dulbecco's Modified Eagle Medium and Nutrient F12 (GIBCO, 
Invitrogen, Carlsbald, CA), 5% heat inactivated fetal bovine serum (Atlanta Biologicals, Atlanta, 
GA) and 1% penicillin and streptomycin as described previously (Broughman et al., 2001). The 
media were refreshed every alternate day. Cells were maintained on plastic 25-cm
2
 cell culture 
flasks (Corning Inc., corning, NY) in a humidified environment with 5% CO2 at 37˚C and 
passaged every 3-4 days after growing to 90 to 100% confluence, treated with 0.25% trypsin and 
2.6 mM EDTA (GIBCO) and dispersed using gentle mechanical force to dislodge the cells from 
cell culture flask surface. For the Ussing chamber experiments, approximately 2.5 x 10
5
 cells 
were seeded onto 1.13 cm
2
 permeable supports (Snapwell, 12-mm diameter, Costar, Corning 
Inc.) 14 days prior to experimental evaluation.  
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Electrophysiology: Transepithelial ion transport was measured using a modified Ussing 
chamber (model DCV9, Navicyte, San Diego, CA) as described previously (Broughman et al., 
2004; Broughman et al., 2001). For typical electrical ion flux measurements, monolayers were 
bathed symmetrically in Ringer solution (120 mM NaCl, 25 mM NaHCO3, 3.3 mM KH2PO4, 0.8 
mM K2HPO4, 1.2 mM MgCl2, and 1.2 mM CaCl2; ～ 290 mOsmol/kg H2O) prepared just before 
use, maintained at
 37˚C and continuously bubbled with 5% CO2/ 95% O2 to provide mixing and 
pH stability. The monolayers were clamped to 0 mV and a 5 s 1 mV bipolar pulse was generated 
automatically every 100 s using a voltage clamp (model 558C-5, University of Iowa,
 
Dept. of 
Bioengineering, Iowa City, IA). The current change in response to the voltage pulse was used to 
calculate transepithelial conductance (gte) according to Ohm‘s law (gte = 1/Rte=∆I/∆V). Data 
were acquired at 1 Hz with an Intel based computer using an MP100A-CE interface and 
AcqKnowledge software (version 3.7.3, BIOPAC
 
Systems, Santa Barbara, CA).  
Data analysis: All numerical results are reported as mean ± SEM. All graphs and 
regression fits were completed using Sigmaplot 2000 (v 10.0, Systat Software Inc, San Jose, CA) 
and/or Excel (v 11.8, Microsoft Corp, Redmond, WA). 
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Results 
 
Channel-Forming Potential  
Experiments were conducted to determine whether these synthesized peptides displayed 
channel-forming activity, as indicated by an increase in short circuit current (Isc). Fig 2.1 shows 
the recordings from typical experiments in which MDCK monolayers were exposed to synthetic 
peptides at two different concentrations, 30 µM and 100 µM. 
MDCK epithelial cell monolayers with low basal gte (1.0 ± 0.1 mS cm
-2
) and low basal Isc 
(0.39 ± 0.04 µA cm
-2
), were pretreated with 300 µM 1-EBIO, an activator of Ca
2+
- dependent 
basolateral K
+
 channels IK and SK, to hyperpolarize the cells and maximize the electrochemical 
driving force for anion secretion (Broughman et al., 2004; Devor et al., 1996). Exposure of 
MDCK monolayers to 1-EBIO resulted in peak Isc of 1.07 ± 0.09 µA cm
-2
 with a slight sustained 
increase in Isc of 0.67 ± 0.07 µA cm
-2
 as well as a slightly increase in gte of 0.23 ± 0.18 mS cm
-2
. 
The changes of Isc were consistent with the activation role of 1-EBIO. The modest effect of 1-
EBIO suggested that the basolateral membrane in MDCK monolayers was not rate limiting for 
anion secretion. After reaching the peak elicited by 1-EBIO, the Isc decreased towards basal Isc 
and attained a value of 0.75 ± 0.09 µA cm
-2
 after ~ 5 minutes. 
   After the pretreatment of 1-EBIO, peptide p1171 dissolved in distilled water with 
concentrations of 30 µM and 100 µM were added to the apical surface of polarized MDCK 
monolayers (Fig 2.1A). Treatment with 30 µM p1171 resulted in a rapid increase of 1.80 ± 0.63 
µA cm
-2
 in Isc within 3 minutes. Similar with 30 µM p1171 treatments, exposure to 100 µM 
p1171 caused an immediate increase of 2.11 ± 0.33 µA cm
-2
 in Isc. After reaching its Isc peak in 
less than 3 minutes, the Isc declined to a value of 1.06 ± 0.29 µA cm
-2
 after more than 16 
minutes. The summary data from 3-5 observations suggested that there was no significant 
difference between two concentrations when comparing the p1171 elicited Isc changes (Fig 
2.1D). 
Exposure of the MDCK monolayers to either p1172 (Fig 2.1B) or p1173 (Fig 2.1C) was 
associated with rapid increases in Isc that reach peak values in a concentration dependent manner 
before declining. Apical exposure to p1172 at 30 µM caused an increase in Isc from 0.68 ± 0.11 
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µA cm
-2
 to 3.21 ± 0.65 µA cm
-2
 in 3 minutes, and then started to decline to baseline but remained 
at 1.73 ± 0.19 µA cm
-2
 after more than 16 minutes. Apical exposure to 100 µM p1172 also 
resulted in an immediate increase in Isc followed by declining to a higher residual Isc after the 
same time course. From Fig 2.1D, it was obvious that the effect of 100 µM p1172 on Isc was 
nearly 2 folds of the effect of 30 µM p1172. Like p1172, peptide p1173 also elicited instant 
increase in Isc at concentrations 30 µM and 100 µM. After peak Isc, the Isc declined toward 
peptide pre-treatment level but remained at an elevated Isc value. The concentration dependent 
effect of peptide p1173 was much greater than p1172. The treatment of 100 µM p1173 caused 
more than 4 fold Isc change than 30 µM p1173 (Fig 2.1D). Meanwhile, there is significant 
difference between Isc changes caused by 100 µM p1172 and 100 µM p1173. It indicates that the 
ion channel forming potential of p1172 and p1173 might be different.  
All MDCK epithelial monolayers responded to forskolin after the effect of the peptides 
had diminished. Forskolin is an adenylyl cyclase activator that induces the conversion of ATP to 
cAMP, which activates protein kinase A. Protein kinase A activates components of active ion 
transport pathways, such as CFTR, which ultimately results in increased anion secretion (Carlin 
et al., 2006; Hedin & Rosberg, 1983). In these MDCK monolayers, the addition of 2 µM 
forskolin resulted in a rapid transient ΔIsc of 22.19 ± 1.22 µA cm
-2
. After the Isc peak, there 
followed a plateau which indicates ongoing anion secretion (data not shown). The Isc changes 
caused by forskolin suggested that MDCK monolayers were still viable and responsive to 
cAMP-mediated stimulation after the exposure to these peptides. 
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Figure 2.1 Synthesized peptides induce elevation in short circuit current across MDCK monolayers.  
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A-C) Representative traces of Isc measured from MDCK monolayers exposed to 1-EBIO and apically to 
synthesized peptides p1171, p1172 and p1173, as indicated. The dashed line represents the reference 
point of zero, indicating no net flux of ions. 
D) Summarized results of synthesized peptides induced Isc change for n=3-5 (± SEM).  
Asterisk (*) indicates significant difference between ΔIsc caused by different concentrations. 
 
 
Conductance change 
 The magnitude of the current change caused by bipolar voltage pulses was used to 
calculate the changes in gte over time. All MDCK monolayers tested had a low basal gte of 0.98 ± 
0.10 mS cm
-2 
and their gte increased to 1.24 ± 0.18 mS cm
-2 
after the pretreatment of 1-EBIO.  
The gte did not change significantly after exposure to p1171, at either concentration tested 
(Fig 2.1A). As opposed to p1171, exposure to peptides p1172 and p1173 showed a definite 
increase in gte associated with changes in Isc.  
Different from Isc, which reached peak value within 3 minutes after apical exposure of 30 
µM and 100 µM p1172, the gte usually began to increase after reaching the peak Isc, even 
continuing to increase during the decline of Isc and generally reaching a maximum value after 
exposure to peptide for ~ 30 minutes. For peptide p1172, the maximal value of gte at 100 µM was 
3.23 ± 0.75 mS cm
-2
, which was more than two-fold of the maximal value of gte at 30 µM, 1.33 ± 
0.28 mS cm
-2 
(Fig 2.2A).  
The conductance increase caused by 30 µM and 100 µM p1173, was similar to p1172 
described above. However the concentration-dependent effect appeared to be more substantial 
for peptide p1173. The maximal value of gte at 100 µM was 3.79 ± 1.05 mS cm
-2 
while the 
maximal value of gte at 30 µM was 1.04 ± 0.13 mS cm
-2 
(Fig 2.2B). The much slower onset of 
Δgte than ΔIsc suggests that there might be different pathways regulated by synthetic peptides to 
account for these different outcomes.  
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Figure 2.2 Synthesized peptides p1172 and p1173 cause a concentration- and time- dependent 
elevation in conductance (gte) across MDCK monolayers. 
A) Peptide p1172 and B) peptide p1173 treatments caused concentration dependent increases in 
conductance with a much slower onset than the increase in short circuit current. n=3-5 (± SEM) 
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Discussion 
The results suggested that p1130 derivatives p1171, p1172 or p1173 can form functional 
ion channels in the apical membranes of MDCK cells grown as monolayer cultures. 
Peptide p1171 is a doubly substituted peptide of p1130.  The uncharged amino acid 
threonine at positions T13 and T17 in NC-1130 were both replaced by the amino acid 
diaminopropionic acid (Rgroup= —CH2—NH3
+
, which has a net positive charge at physiological 
pH). The addition of cation residues to the transmembrane sequence might potentially interfere 
with the membrane insertion and assembly steps.  Therefore, electrophysiological experiments 
were conducted to examine whether p1171 still have an ion channel forming potential.  
The doubly substituted peptide p1171 induced a rapid increase in Isc, which suggests that 
after cationic amino acids replacement, the peptide can still form stable ion-conducting pores. 
However, there is no big difference between ΔIsc caused by 30 µM and 100 µM. According to 
Hill equation, when the concentration of substrate is much higher than the apparent Kd, then the 
reaction rate will be affected by concentration. It is possible that at a concentration of 30 µM, 
ΔIsc has already reached its maximal value. Therefore, 100 µM will be expected to have the same 
effect on Isc. It is also possible that the concentrations at 30 µM and 100 µM are too low from a 
working concentration of p1171 to cause a difference effect on ΔIsc across MDCK monolayers. 
Further experiments can be done by testing lower concentrations (100 pM, 300 pM, 1 µM) and 
higher concentrations (1 mM, 3 mM, 10 mM) of p1171 to determine the complete concentration 
dependency.  
Peptide p1172 is formed by adding a four-residue sequence ILTG to NC-1130 while 
peptide p1173 is formed by adding a seven residue sequence ILTGILT. The channel-forming 
sequence p1130 induces an apparent thinning of the membrane according to computer modeling. 
Membrane thinning has been observed with a number of pore-forming antimicrobial peptides 
and it seems to be a general phenomenon associated with pore formation (Huang, 2006; Jang, et 
al., 2006).  
The increases in Isc after exposure to either p1172 or p1173 suggest that either peptide 
can increase ion transport and elicit anion secretion or cation absorption. Compared with p1130, 
which has 22 amino acids and whose membrane spanning length is 18 amino acids, peptide 
p1172 with one more helical turn elicited higher Isc change and gte change. And the longest 
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sequence discussed here, p1173, which is predicted to have two more helical turns than p1130, 
had the highest effect in Isc and gte in all three peptides. Meanwhile, the elevations of gte suggest 
that synthesized peptides p1172 and p1173 might modulate epithelial transport, and possibly 
through the paracellular route.  
The peptide p1130 is remarkable in several ways: 1) it is small and easily synthesized; 2) 
it is water soluble and can be delivered to membrane surfaces without the need of added organic 
solvents; 3) it is predominantly monomeric in solution; 4) when inserted into membranes it 
orients in the same direction due to the highly positively charged N-terminus; 5) the pore form 
through self-association contains helices in a parallel orientation; 6) functional ion conducting 
pores are formed that can provide information on various channel properties; and 7) the small 
size of the peptide and the assembled pore facilitates both structural analyses and computer 
modeling that can produce informative structures. All three derivatives of p1130, peptides 
p1171, p1172, p1173 showed ion channel forming potential. Further study might focus on 
PCl/PNa and PCl/PK to define the exact value of anion selectivity of these synthetic peptides in 
order to determine whether changing pore residue electrostatics and changing pore length would 
increase anion selectivity of p1130. Our final purpose is try to find a p1130 derivative with all 
the original advantages of p1130 as well as higher anion to cation selectivity, this sequence 
would be ideal for enhancing apical Cl
-
 conductance and can be served as a substitute for 
endogenous Cl
-
 channels for the treatment of cystic fibrosis. 
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A previous version of this chapter was included as a part of Dr. Suma Somasekharan‘s 
PhD thesis that is available through Kansas State University libraries (―NC-1059, a Channel 
Forming Peptide, Induces a Reversible Change in Barrier Function of Epithelial monolayers‖, 
2008, p83-124, available at http://hdl.handle.net/2097/553). The chapter included in Dr. 
Somasekharan‘s thesis was submitted to a journal for peer review. Subsequently, the manuscript 
was revised substantially to address reviews‘ concerns. Additional experiments that constitute a 
substantial portion of the research project conducted to complete the master degree requirements 
were added to this chapter. New data were added to demonstrate that NC-1059 modulates F-
actin:total actin ratio. New data were also added to rule out the possibilities that the change of 
tight junction permeability was caused by cell loss from the monolayer or caused by an effect on 
cell viability. Significant contributions were made to Figs 3.4, 3.5, 3.7, 3.9, 3.10, 3.13 and 3.14. 
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Abstract 
The goal of this study is to determine cellular changes that account for increased 
epithelial paracellular permeability by NC-1059, a synthetic channel forming peptide. Apical 
exposure to NC-1059 (60 μM) was shown previously to increase short circuit current, 
transepithelial electrical conductance (gte) and enhanced the permeation of 9.5 kDa dextran, but 
not 77 kDa dextran across MDCK monolayers, all of which returned to pretreatment levels 
within 48 hrs after removal of the peptide from the apical medium. MDCK monolayers in the 
present study showed a large increase in gte and enhanced permeation of 40 and 70 kDa dextran 
when exposed to NC-1059 at greater concentrations (100 and 200 μM). Following exposure to 
NC-1059 for 60 min, epithelial monolayers showed a substantial recovery in gte at 24 hrs and 
returned to pretreatment values within 48 hours. Immunolabeling and immunoblotting revealed 
an NC-1059 associated decrease in the F-actin to G-actin ratio and concentration dependent 
reorganization or loss of actin cytoskeleton, tight junction proteins ZO-1 and occludin and 
adherens junction proteins E-cadherin and β-catenin that occurred over a 15 to 60 min period. 
Effects of NC-1059 exposure were reversible with progressive recovery of immunoreactivity at 
the apical cell junction for occludin and ZO-1 observed 24 and 48 hrs post exposure. The 
modulation of the epithelial tight junctions in a reversible manner indicates that NC-1059 has 
therapeutic potential to increase the efficiency of drug delivery across barrier membranes. 
 
Key words: Occludin, ZO-1, Actin, Paracellular permeability, Transepithelial 
conductance 
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Introduction 
NK4-M2GlyR (KKKKPARVGLGITTVLTMTTGSSGSRA) is a channel forming peptide 
that was synthesized by adding four lysine residues to the second transmembrane segment (M2) 
of the glycine receptor (GlyR) alpha-subunit (Broughman et al., 2001; Tomich et al., 1998; 
Wallace et al., 1997) and was shown to increase anion secretion by epithelial monolayers. 
However, the subsequent removal of up to five C-terminus residues from NK4-M2GlyR reduced 
aggregation of the peptide in aqueous solution while retaining ion transport properties 
(Broughman et al., 2001). Based on the hypothesis that only the N-terminus half of the peptide 
was necessary for its ion transport properties, a palindromic peptide was designed with 11 
residues from the N-terminal half of NK4-M2GlyR. The final sequence, KKKKAARVGLGITTV 
LVTTIGLGVRAA, was termed NC-1059 (Broughman et al., 2004). 
NC-1059 enhances ion transport and reduces barrier function of epithelial monolayers. 
MDCK monolayers that were exposed apically to NC-1059 showed a concentration dependent 
increase in short circuit current (Isc), demonstrating an increase in anion secretion or cation 
absorption. The transepithelial electrical conductance (gte), a measure of epithelial barrier 
function, also increased in a concentration dependent manner (Broughman et al., 2004). Similar 
outcomes have now been reported for epithelia derived from cornea (Martin et al., 2009), colon, 
airway, and reproductive duct (Somasekharan et al., 2008). Furthermore, NC-1059 enhanced 
dextran permeation across epithelial monolayers, showing that a paracellular route was opened 
(Broughman et al., 2004). The effect of the peptide on gte and paracellular solute movement was 
reversed within 48 hrs of returning the monolayers to fresh culture medium. The cell monolayers 
regained responsiveness to subsequent treatments with the peptide (Broughman et al., 2004; 
Martin et al., 2009). Thus the effects of NC-1059 on epithelial monolayers are reversible and 
repeatable. 
Epithelial cell layers act as barriers to the movement of hydrophilic or uncharged solutes. 
Tight junctions are multimolecular complexes located between the apical intercellular regions of 
epithelial cells that regulate paracellular permeability (Schneeberger & Lynch, 2004). Occludin, 
claudins, junctional adhesion molecule-1 (JAM-1) and zona occludens protein-1 (ZO-1), along 
with other proteins form the tight junctions (Schneeberger & Lynch, 2004). This tight junction 
complex associates with the perijunctional actomyosin ring and the complex is proposed to be 
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involved in regulation of solute movement through the paracellular route (Madara, 1998). 
Compounds such as bacterial and fungal toxins (e.g., Clodtridium difficle toxins, ochratoxin), 
positively charged molecules (e.g., protamine) and chitosans are amongst several molecules 
observed to cause an increase in gte through an effect on actin organization and/or localization of 
junctional proteins (McLaughlin et al., 2004; Moore et al., 1990; Peixoto & Collares-Buzato, 
2005; Schipper, Varum & Artursson, 1996). Peptides corresponding to the first and second 
extracellular loops of occludin also increased paracellular permeability, although several hrs 
were required to produce significant effects (Chung et al., 2001; Wong & Gumbiner, 1997). A 
modified occludin peptide reportedly enhanced permeability across airway epithelia and caused a 
loss in occludin localization at the tight junctions (Tavelin et al., 2003). Vibrio cholerae produces 
zonula occludens toxin (ZOT), a naturally occurring peptide that increases the permeability of 
small intestine epithelia (Fasano et al., 1997). ZOT is rapid in onset (<20 min) and the effects are 
reversible. ZOT causes reorganization of actin and a change in the localization of ZO-1 (Fasano 
et al., 1995). VP8, a rotavirus surface protein, enhances paracellular permeability by causing a 
redistribution of occludin, ZO-1 and claudin-3 at the tight junctions in MDCK monolayers (Nava 
et al., 2004). These results suggest that the actin cytoskeleton and proteins comprising the tight 
junctions can be modulated either in distribution or abundance to affect epithelial barrier 
function. 
Adheren junctions also contribute to the epithelial barrier. E-cadherin is a transmembrane 
adheren junction protein that self associates in the extracellular space and associates with the 
actin cytoskeleton through β-catenin intracellularly. These interactions are important in 
maintaining cell morphology and are thought to be important for paracellular permeability 
(Hartsock & Nelson, 2008). Additionally, E-cadherin and β-catenin are important players in the 
assembly of the tight junctions (Gumbiner, 2005; Rajasekaran et al., 1996). Disruption of E-
cadherin is associated with an increase in paracellular permeability with an associated change in 
actin organization and the organization of other junctional proteins (Wu et al., 1998; Wu et al., 
2007; Wu et al., 2006). Hence, a pronounced reorganization in actin might involve a change in 
distribution of E-cadherin and β-catenin. 
The focus of this study is to establish the molecular basis that accounts for NC-1059 
enhancement of the permeability across MDCK monolayers. It was hypothesized that NC-1059 
alters the localization of one or more junctional proteins. Also, since the actin cytoskeleton plays 
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a significant role in regulating paracellular permeability, NC-1059 was speculated to induce 
changes in permeability by altering actin organization. The outcomes show that NC-1059 
exposure is associated with changes in both the abundance and localization of junctional proteins 
and that these effects were fully reversible in MDCK cells over 24-48 hours. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 41 
Methods 
Peptide Synthesis: NC-1059 was synthesized as described previously by solid phase 
synthesis using 9-fluorenylmethoxycarbonyl chemistries (Broughman et al., 2002). The peptide 
was purified by reversed-phase HPLC and characterized by Edman degradation and matrix-
assisted laser desorption time of flight mass spectroscopy (Broughman et al., 2002). 
Chemicals: A 4% paraformaldehyde solution in phosphate buffered saline (PBS) was 
prepared from a 16% paraformaldehyde stock (Electron Microscopy Sciences, Hatfield, PA). 
Peptide stocks of 5 mM or 8 mM were prepared in deionized water just prior to use. Unless 
otherwise indicated, chemicals used were reagent grade obtained from Sigma Aldrich (St. Louis, 
MO). 
Cell culture: MDCK cells were obtained from Dr. Lawrence Sullivan (University of 
Kansas Medical Center, Kansas City, KS) and grown in a medium containing a 1:1 mixture of 
Dulbecco's Modified Eagle Medium (DMEM) and Nutrient F12 (GIBCO, Invitrogen, Carlsbald, 
CA), 5% heat inactivated fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, GA) and 1% 
penicillin and streptomycin as described previously (Broughman et al., 2004; Broughman et al., 
2001). PVD9902 cells, epithelial cells derived from porcine vas deferens, were grown in a 
medium containing DMEM, 10% heat inactivated FBS and 1% penicillin and streptomycin as 
described previously (Carlin et al., 2006; Somasekharan et al., 2008). Cells were grown in plastic 
25-cm
2
 cell culture flasks (Corning, Inc., Coring, NY) in a humidified incubator with 5% CO2 at 
37ºC. Cultures that were >90% confluent were treated with 0.25% trypsin and 2.6 mM EDTA 
(GIBCO) and gentle mechanical force was used to dislodge cells from the surface. 
Approximately 2x10
5
 cells were seeded onto 1.13 cm
2
 permeable supports (Snapwell, Costar, 
Corning Inc.) and cultured for 14 days prior to experimental evaluation. A tenth of the cells were 
also seeded onto flasks for further passages. The media were refreshed every alternate day. 
Electrical Measurements: Isc and transepithelial electrical potential were measured using a 
modified Ussing Chamber (model DCV9, Navicyte, San Diego, CA) as described previously 
(Broughman et al., 2004; Broughman et al., 2001). Monolayers were bathed symmetrically with 
Ringer solution (in mM: 120 NaCl, 25 NaHCO3, 3.3 KH2PO4, 0.8 K2HPO4, 1.2 MgCl2, and 1.2 
CaCl2) that was prepared fresh daily, maintained at
 
37ºC and bubbled with 5% CO2-95% O2 to 
achieve continuous mixing and to maintain pH. The monolayers were clamped to 0 mV and a 5 s 
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1 mV bipolar pulse was applied every 100 s using a voltage clamp (model 558C-5, University of 
Iowa,
 
Dept. of Bioengineering, Iowa City, IA). Data acquisition was
 
performed at 1 Hz using an 
Intel based computer and MP100A-CE interface (v. 3.2.6, BIOPAC
 
Systems, Santa Barbara, 
CA). The current measured in response to the voltage pulse was used to calculate gte (gte = 
∆I/∆V). 
FITC-Dextran permeability assay: Dextran permeation through the monolayer was 
measured as described previously (Broughman et al., 2004). The medium was removed and the 
monolayers were washed with warmed PBS. Ringer solution was added to the basolateral (1 ml) 
and apical (200 μl) compartments in the Snapwell culture plate. NC-1059 (200 μM) or vehicle 
was added to the Ringer solution on the apical side of the monolayers. Paired monolayers were 
exposed to 5 mM EDTA in hypotonic Ringer solution (50% dilution with water). Dextran (40 or 
70 kDa) conjugated to FITC (0.5 mg) was added to the apical compartment of all treatments. 
After incubation at 37ºC for 1 hr samples were taken from the basolateral compartment for 
determination of fluorescence intensity (Fluorskan Ascent FL, Thermo Fisher Scientific, 
Waltham, MA). A series of dilutions of each size of dextran was prepared and fluorescence 
determined as a function of concentration. A linear regression was used to derive the slope and 
calculate the amount of dextran that permeated each monolayer.  
Recovery experiments: Monolayers were mounted into modified Ussing chambers and Isc 
and gte measured as described. Monolayers were exposed to either 100 or 200 μM NC-1059 or 
vehicle (Ringer solution) for 60 min and returned to the incubator in the presence of fresh culture 
medium for either 24 or 48 hrs before gte was assessed again. Monolayers were fixed 
subsequently with 4% paraformaldehyde and labeled with anti-occludin and anti-ZO-1 
antibodies as described below.  
Cell counting: MDCK cells grown to >90% confluent in plastic 25-cm
2
 cell culture flasks 
were detached from the surface and adjacent cells by treating with 0.25% trypsin and 2.6 mM 
EDTA followed by gentle mechanical force. Cells were suspended in 1 ml cell culture medium 
and samples were loaded into the chamber of a hemacytometer (Hausser Scientific Company, 
PA) to determine cell density using darkfield microscopy (Nikon, Inc., Melville, NY). 
Approximately 3×10
4
, 1×10
5
, 3×10
5
, 1×10
6
 cells were seeded onto 1.13 cm
2
 permeable supports 
and assessed in modified Ussing chambers after 24 and 48 hrs growth as described above. 
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Cell membrane integrity assay: Lactate dehydrogenase (LDH) is released from cells that 
have compromised membranes that is indicative of cell death. LDH activity was measured in 
medium bathing the apical aspect of MDCK cells using a commercially available fluorescence-
based kit (CytoTox-ONE; Promega Corp., Madison, WI). LDH activity was assessed using 
MDCK cells grown on both solid supports as outlined for the best performance of the kit and 
using cells grown on permeable supports as is typical for assessment of ion transport and barrier 
function. In initial studies, MDCK cells were seeded onto sterile 96-well opaque-walled tissue 
culture plates (Nalge Nunc International Corp., Rochester, NY) at a density of 1×10
5
 cells/well. 
After 72 hours, cells were treated with vehicle, NC-1059 (200 µM) or EDTA (5 mM) for 60 min. 
Lysis solution (2 µL) was added to cells in paired wells to determine maximal LDH release. 
LDH activity was measured fluorometrically according to the manufacturer‘s instructions with 
outcomes reported in arbitrary fluorescent units. Assays were conducted to verify that the rate of 
increase in fluorescence was linear over the 10 min duration of the incubation and that the rate of 
increase in fluorescence was proportional to the volume of supernatant used for the assay. 
Subsequently, experiments were conducted with MDCK cells grown on permeable supports for 
14 days. Monolayers were washed with warmed PBS were treated with vehicle, NC-1059 or 
EDTA for 1 hour or with lysis solution to achieve maximal LDH release. Five µL of the apical 
medium was employed to determine LDH activity in each condition as described above.    
Immunolabeling: MDCK monolayers were exposed to NC-1059 for 5, 15, 30 and 60 min. 
NC-1074 (KKKKARSGSSQTTMTLARSGSSQTTMT), a peptide that does not elicit changes in 
epithelial electrical parameters, or vehicle was used to verify specificity of the NC-1059 effects. 
Following exposure to peptide or vehicle, monolayers were fixed with 4% paraformaldehyde and 
then incubated with anti-occludin (Zymed, Carlsbad, CA) or anti-ZO-1 (Chemicon, Temecula, 
CA and Zymed) antibodies and with Alexa 488 conjugated phalloidin (Molecular Probes, 
Carlsbad, CA). In a third set of experiments, MDCK monolayers were exposed to vehicle or NC-
1059 for 30 or 60 min. Monolayers were fixed subsequently and labeled with anti-E-cadherin 
(Hybridoma bank, University of Iowa, Iowa City, IA) or anti-β-catenin (BD Biosciences, San 
Jose, CA) antibodies. Secondary antibodies were conjugated to Alexa 488 (green), Alexa 594 
(Red) or rhodamine (Red). TOPRO-3 (blue; Molecular Probes) was used to label the nucleus. 
Images were acquired using a confocal microscope (LSM 510, Carl Zeiss AG, Jena, Germany). 
Optical sections (0.8 μm) were obtained along the Z-axis from the apical to basolateral aspect of 
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the cells to make a Z-stack. Three-dimentional projection was used to obtain a composite view of 
selected regions within the Z-stack.  
Immunoblotting: Proteins were extracted from MDCK monolayers following exposure to 
NC-1059 or vehicle. Monolayers were lysed using RIPA buffer (composition: 150 mM NaCl, 10 
mM HEPES, 2 mM EDTA, 1% Triton X-100, 0.2% SDS, 0.5% sodium deoxycholate) with 
protease inhibitor cocktail III (Calbiochem, San Diego, CA) and Halt phosphatase inhibitor 
cocktail (Pierce, Rockford, IL), and the lysate was passed repeatedly through a 21 gauge needle. 
The lysate was incubated at 4ºC for 1 hr and then centrifuged at 4ºC and 14,000g for 15 min. The 
supernatant was collected and protein concentration determined using the bicinchoninic acid 
(BCA) method using albumin as the standard (Pierce). The supernatants were mixed with 5x 
Laemmli sample buffer (250 mM Tris base, 40% glycerol, 0.8% SDS, 20% β-mercaptoethanol 
and 0.01% bromophenol blue). Equal amounts of protein (15 to 35 μg) for each treatment were 
loaded onto 4-15% gels (Biorad, Hercules, CA) and resolved at a 140 mV for 1 hr in running 
buffer (25 mM Tris Base, 200 mM Glycine, 0.1 % SDS). Proteins were transferred onto 
Immobilon–P transfer membranes (Millipore, Billerica, MA) for four hrs at 50V with transblot 
buffer (25 mM Tris base, 192 mM glycine, 20% v/v methanol). The membranes were blocked 
with 5% blotting grade milk (Biorad) in TBS (20 mM Tris base, 0.8% NaCl, pH 7.6) with 0.1% 
Tween-20 for 2 hours. Subsequently, the membranes were probed with either anti-occludin Mab 
(BD Biosciences), anti-ZO-1 Mab (Zymed), anti-E-cadherin, anti-β-catenin or anti-GAPDH Mab 
(Abcam, Cambridge, MA). HRP-conjugated anti-rabbit and anti-mouse secondary antibodies 
(Amersham Biosciences, Piscataway, NJ) were used for detection. Chemiluminiscent substrates 
Super Signal West Pico and Femto (Pierce) were used for development. Images were obtained 
(Kodak Image Station 4000 R, Kodak, Rochester, NY) and digitized (UN-SCAN-IT, Silk 
Scientific, Inc, Orem, Utah) to compare labeling intensity. The net intensity of the signal 
detected for each immunoreactive band was normalized by using the net intensity of GAPDH 
immunoreactivity in each lane as a loading control. The normalized intensity of vehicle-treated 
cell lysates was used as a benchmark for comparison in each condition. 
F-actin/total actin ratio: The relative amount of filamentous actin (F-actin) and globular 
actin (G-actin) in MDCK and PVD9902 cell lysates was measured using a commercially 
available kit (BK037, Cytoskeleton, Denver, CO). Cells were homogenized in a lysis buffer that 
stabilizes F-actin (50 mM PIPES, pH 6.9, 50 mM KCl, 5 mM MgCl2, 5 mM EGTA, 5% glycerol, 
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0.1% Nonidet P40, 0.1% Triton X-100, 0.1% Tween 20, 0.1% 2-mercapto-ethanol, 0.001% 
Antifoam C, 1 mM ATP, 1 µg/ml pepstatin, 1 µg/ml leupeptin, 10 µg/ml benzamidine, 500 
µg/ml tosyl arginine methyl ester). Cell lysates were centrifuged at 2000 rpm for 5 min to pellet 
unbroken cells, which were discarded. F-actin was separated from G-actin in the supernatant by 
centrifugation at 100,000g for 60 min at 37ºC. The F-actin-containing pellet was resuspended in 
ice cold water containing 2 µM cytochalasin D to the same volume as the G-actin-containing 
supernatant and incubated on ice for 1 hr to dissociate F-actin. Equal volumes of supernatant 
(containing G-actin) and dissociated pellet (F-actin) were subjected to immunoblot analysis 
using anti-actin antibody (AAN01; Cytoskeleton) and the F-actin/total actin ratio was determined 
by scanning densitometry as described. 
Data analysis: All numerical results are reported as mean ± SEM. All graphs and 
regression fits were completed using Sigmaplot 2000 (v 6.0, SPSS Inc, Richmond, CA) and/or 
Excel (v 11.8, Microsoft Corp, Redmond, WA). The student‘s t-test (Sigmaplot) and ANOVA 
(Excel) were used for statistical analysis where appropriate. Differences between means were 
considered statistically significant if the probability of a type I error was <0.05.  The time course 
for NC-1059 induced changes in gte was determined by fitting a sigmoidal function (Eqn. 1) to 
values of gte that were calculated every one hundred seconds throughout each experiment using 
the time of NC-1059 exposure as the starting point (i.e., t=0).  
b
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 Eqn. 1 
In Eqn. 1, gte min is the baseline conductance and Δgte max is the peak change in 
conductance reached during the recording for each NC-1059 concentration. b is inversely 
proportional to the slope at half Δgte max and t0 is the time taken to reach half Δgte max. The data 
used for the fit from each experiment were restricted to ~300 s after the peak gte was reached. 
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Results 
NC-1059 induces a concentration dependent change in gte. 
The average change in the gte in response to 100 and 200 μM NC-1059 as a function of 
time is provided in Fig 3.1. The graph reveals that the conductance increased with peptide 
exposure from 0.56 ± 0.09 mS cm
-2
 to a maximal value in about 30 min and remained elevated 
throughout the experiment. A significant increase in gte was observed with 100 μM (8.52 ± 1.17 
mS cm
-2) and several fold greater response was observed with 200 μM (32.32 ± 1.18 mS cm-2) 
NC-1059. The half-maximal response occurred more quickly as indicated by lag time (t0) and 
slope (b) with exposure to 200 µM (t0 = 14.6 ± 0.6 and b = 4.71 ± 0.51 min) as compared to 100 
µM NC-1059 (t0 = 23.4 ± 1.0 and b = 7.01 ± 0.97 min).  
gte is a composite measure of the transcellular and paracellular conductances. The 
substantial increase in gte after exposure to NC-1059 is consistent with the introduction of ion 
channels in the apical membrane and suggests that a paracellular route is opened, as reported 
previously (Broughman et al., 2004). As previously reported, exposure of MDCK monolayers to 
60 μM NC-1059 resulted in a 5 fold increase in permeation of 9.5 kDa dextran, whereas 
permeation of ≥77 kDa dextran was not enhanced by NC-1059 (Broughman et al., 2004). 
However, further experiments conducted with other epithelial cell types showed that 200 μM 
NC-1059 enhanced permeation of 40 and 70 kDa dextran (Somasekharan et al., 2008). Hence 
experiments were conducted to measure permeation of intermediate sizes of dextran across 
MDCK monolayers, in the presence of NC-1059. 
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Figure 3.1 NC-1059 induces a concentration dependent change in gte. 
The average change in gte (±SEM) with 100 μM (■) and 200 μM (▲) NC-1059 as a function of time is 
shown. Epithelial monolayers were exposed continuously to the indicated concentration of peptide in the 
apical bath beginning at the zero time point. The solid lines represent the best fit to Eqn. 1 to each data 
set. Parameters of the fit are reported in the text. Results are summarized from n=3. 
 
NC-1059 can allow for the permeation of 40 and 70 kDa dextran across MDCK monolayers. 
 Dextran permeation across monolayers exposed to vehicle, 200 µM NC-1059 or EDTA 
in hypotonic buffer over a duration of 1 hr was measured (Fig 3.2). Monolayers exposed to 
EDTA showed a large enhancement in permeation for both 40 and 70 kDa dextran relative to 
vehicle treated monolayers. NC-1059 also enhanced permeation of 40 and 70 kDa dextran 
relative to vehicle treated monolayers. However the fold enhancement was small compared to 
EDTA, a compound that has a disruptive effect on epithelia. These results support observations 
made with other cell types (Martin et al., 2009; Somasekharan et al., 2008) and indicate that the 
paracellular route is partially opened by NC-1059 to allow permeation by various size dextrans 
across MDCK monolayers. 
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Figure 3.2 NC-1059 allows for the movement of uncharged molecules across MDCK epithelial 
monolayers. 
FITC conjugated dextran of 40 and 70 kDa was added to the apical compartment and appearance of 
fluorescence in the basolateral compartment was quantified in the presence of one of three treatments 
(EDTA, NC-1059 or vehicle) as described in methods. Results are summarized from n=3. 
 
Monolayers recover gte. 
The gte of MDCK monolayers treated with 100 μM NC-1059 was observed to return to 
pretreatment levels within 48 hrs after exposure (Broughman et al., 2004). Hence experiments 
were conducted to compare the pattern of recovery in gte in monolayers treated with 100 and 200 
μM NC-1059.  
The increase in gte observed upon exposure to either 100 or 200 μM returned to 
pretreatment levels over a duration of 48 hrs (Fig 3.3). Monolayers were exposed to NC-1059 or 
vehicle for 60 min and then placed back in typical culture conditions for 24 or 48 hrs. 
Monolayers that were exposed to 100 (Fig 3.3A) or 200 μM NC-1059 (Fig 3.3B) for 60 min 
showed a significant increase in gte. After 24 hrs the gte decreased toward pretreatment levels and 
reached values that were less than 18% of the peak value with 100 μM and less than 12% of peak 
value with 200 μM, but remained significantly greater than pretreatment. In 48 hrs the gte 
decreased further, to pretreatment levels. 
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Figure 3.3 Monolayers exposed to 100 and 200 μM NC-1059 recover to pretreatment gte within 48 
hours. 
Recovery in gte after exposure to 100 μM (A) or 200 μM (B) NC-1059 is shown. Monolayers were 
exposed to vehicle or NC-1059 for 60 min and returned to the incubator. gte was subsequently measured 
after 24 hrs and 48 hrs for each pair (vehicle and NC-1059 treated) of monolayers and results are 
summarized from n=3. Asterisk (*) indicates significant difference from vehicle. 
 
NC-1059 has no apparent effect on epithelial cell density. 
 Media or buffer removed after cell monolayers were exposed to NC-1059 were 
indistinguishable from those that had been exposed to only the vehicle – there was no indication 
of cells or cell debris in the spent medium. Nonetheless, experiments were conducted to 
determine whether cell loss might account for the increase in conductance caused by NC-1059. 
gte was assessed one or two days after seeding different densities of MDCK cells onto culture 
supports (Fig 3.4). Culturing ≤105 cells for 24 or 48 hrs showed very high conductances of >40 
mS cm
-2
 after 1 day or 2 days in culture. This outcome suggested that ≤100,000 cells is too few 
to form a confluent monolayer in the 1.13 cm
2
 permeable supports within 2 days. When a high 
density of cells (≥106) was seeded, a low conductance of <1 mS cm-2 was observed within one 
day. It should be noted that MDCK cells typically grow to a density of ~10
6
 cells cm
-2
, or 
~1.1×10
6
 cells per Snapwell support. As shown in the figure, seeding 300,000 cells resulted in a 
conductance measured after 24 hrs that was greater than the conductance immediately following 
exposure to 100 µM NC-1059, and that, with an additional 24 hrs in culture conductance values 
approached those of a mature monolayer. These results suggest that >300,000 cells (i.e., a 
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virtually confluent monolayer) must be present on the permeable support following exposure to 
NC-1059 to achieve conductances of <5 mS cm
-2
 within 24 hours, as is observed. Normally 
~2×10
5
 cells were seeded onto permeable supports and cultured for 14 days prior to mounting in 
a modified Ussing chamber for assessing gte and Isc (e.g., Fig 3.3). If NC-1059 causes a loss of cells 
from the monolayer, more than 500,000 cells would have to have been lost to account for the highest 
conductance observed, an amount that would have been obvious when removing spent media. 
Furthermore, >300,000 cells would be required on the filter support to achieve the conductance that was 
measured after 24 hrs. The results suggest that cell loss from the monolayer and proliferation of 
remaining cells cannot account for the changes in conductance that are observed. Rather, the 
outcome suggests a change of tight junction permeability without a loss of epithelial cells from 
the confluent monolayer.  
 
Figure 3.4  Low cell densities fail to form a resistive monolayer within 48 hours. 
gte was assessed in modified Ussing chambers 24 and 48 hrs following the seeding of the indicated 
number of cells on a permeable culture support (1.13 cm
2
). Results are summarized from n=4-6 at each 
seeding density and time point. 
 
NC-1059 has no effect on lactate dehydrogenase (LDH) release. 
LDH release was measured to determine whether NC-1059 compromises cell membrane 
integrity and by inference, cell viability. A commercial kit was used in which florescence is 
proportional to LDH activity in the cell culture medium. In initial assays, MDCK cells were 
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cultured on 96-well plates to test for NC-1059 induced LDH release. MDCK cells exposed to 
NC-1059 (200 µM) for 60 min showed an LDH release that was not different from vehicle alone 
while paired cells exposed to EDTA (5 mM) exhibited significantly greater LDH release into the 
medium (Fig 3.5A). The effects of NC-1059 on LDH activity released from MDCK monolayers 
cultured on permeable supports was also tested. Similar with the result reported for cells grown 
on solid supports, the LDH activity released from NC-1059 treated cells was indistinguishable 
from those exposed to vehicle only, while EDTA exposure was associated with an apparent 
doubling of LDH activity in the apical medium (Fig 3.5B). These outcomes indicate that NC-
1059 has no measurable effect on cell membrane integrity and thus, even at the concentration 
tested (200 µM) and the duration of exposure (60 min) there is no observable effect on cell 
viability.  
 
Figure 3.5 NC-1059 has no effect on cellular lactate dehydrogenase (LDH) release. 
MDCK cells were grown on 96 well plates for three days (A) or on transwell permeable supports for 14 
days (B) and exposed to NC-1059 (200 µM), EDTA (5 mM) or vehicle for 60 min. Cells in paired wells 
were lysed to determine maximum LDH activity. LDH activity in the apical medium is proportional to 
fluorescence at 590 nm. Results are summarized from 8 experiments on each cell culture platform. 
Asterisk (*) indicates significant difference from vehicle.  
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NC-1059 exposure causes actin reorganization. 
Experiments were conducted to determine the effect of NC-1059 on actin organization as 
a function of time (Fig 3.6A). Images of the phalloidin (i.e., F-actin)-labeled monolayers were 
obtained as optical sections along the Z-axis. Sections were divided into apical, middle and basal 
regions and each panel presented in the figure is a composite projection of 4-6 optical sections. 
F-actin fibers are present throughout all portions of all cells in the monolayer. Each cell is 
circumscribed clearly by the perijunctional actomyosin ring in the apical region. There is also 
central punctate labeling of F-actin fibers in the apical region. The middle and basal sections 
show cortical actin filaments. In the most basal sections, actin filaments appear bundled and 
might constitute stress fibers. Exposure of the monolayer to NC-1059 (200 μM) for 5 min 
revealed little change in the F-actin labeling along the entire depth of the monolayer. The 
intensity of the labeling of central actin fibers and perijunctional actomyosin ring in some areas 
was reduced at 15 min. The images clearly show regions of the monolayer in which the apical 
sections exhibited no labeling while adjacent cells remained fully circumscribed. After 30 min of 
NC-1059 exposure an overall decrease in labeling intensity was observed in the apical, middle 
and basal sections of the Z-stack. Relative to the 15 minute time point, larger regions of the 
monolayer were devoid of F-actin labeling, especially at the apical regions. At the same time, the 
labeling of the perijunctional actomyosin ring was intensified in the remaining cells. After 60 
min of NC-1059 exposure the labeling of apical actin fibers was dramatically reduced. There was 
a reduction in the punctate labeling of F-actin fibers apically and a pronounced decrease in 
labeling intensity of the perijunctional actomyosin ring. There was also a pronounced reduction 
in the labeling of fibers in the middle and basal portions of the cells. The reduction in the 
intensity of labeling both at the perijunctional actomyosin ring and F-actin fibers throughout the 
Z-stack suggested a disruption in the organization of the actin cytoskeleton in NC-1059 treated 
monolayers. Monolayers exposed to NC-1074, a scrambled sequence of NK4-M2GlyR that does 
not elicit any changes in ion transport, showed a phalloidin labeling pattern comparable to 
vehicle exposed monolayers, which suggests that the effect on actin organization was specific to 
the NC-1059 sequence.  
NC-1059 has a concentration dependent effect on gte and it is likely that the effect of NC-
1059 on actin organization might also follow a concentration dependent pattern. The patterns of 
actin organization in MDCK monolayers exposed to 100 and 200 μM NC-1059 reveal that there 
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is a modest but perceptible difference in the effect of these concentrations on actin organization 
(Fig 3.6B). Exposure of monolayers to 100 μM NC-1059 for 30 min caused a reduction in the 
labeling of the actin fibers along all regions of the Z-stack. Large areas showed a pronounced 
decrease in F-actin labeling intensity, both centrally and along the perijunctional actomyosin 
ring. However, some cells exhibited an enhanced intensity especially along the perijunctional 
actomyosin ring. After 60 min of exposure with 100 μM NC-1059, there was a decrease in 
labeling intensity of F-actin throughout most cells. The results observed with 200 μM NC-1059 
were consistent with observations made in the previous experiment at the corresponding time 
points. The middle and basal sections show a further decrease in labeling intensity after 60 min 
of exposure with both concentrations. However it might be noted that after 60 min of exposure to 
200 μM NC-1059, the labeling of the preijuntional actomyosin ring, although substantially 
decreased in intensity, is still circumscribing all cells. 
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Figure 3.6 NC-1059 causes actin reorganization within MDCK cells. 
A) Time course of the effects of NC-1059 on actin organization. Panels show images of monolayers 
labeled with Alexa-conjugated phalloidin. Images show typical F-actin labeling in monolayers that were 
exposed to vehicle, NC-1059 (200 μM), or NC-1074 (200 μM) for the indicated durations. B) Effect of 
100 and 200 μM NC-1059 on actin organization. Monolayers were exposed to vehicle or NC-1059 at the 
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concentrations and durations indicated, and labeled with Alexa-conjugated phalloidin. All images are 3-D 
projections of the respective Z-stacks obtained using confocal microscopy. In both panels, the results are 
a typical example of n=4 and from paired monolayers. 
 
NC-1059 alters the F-actin:total actin ratio in epithelial cell. 
Immunoblotting was conducted to determine whether the abundance of F-actin is affected 
by NC-1059 exposure. Fig 3.7A includes immunoblots of G-actin (G) and F-actin (F) 
immunoreactivity derived from MDCK monolayers after apical exposure to vehicle, NC-1059 
(200 µM) for 60 minutes, or NC-1059 for 60 minutes followed by 48 hrs recovery. Results from 
initial experiments showed little F-actin immunoreactivity in MDCK cells and densitometric 
analysis after background subtraction detected very low amounts (~10% of total actin), although 
the detection was consistent. Therefore, assays were conducted with 3T3 cells, which have been 
used for this assay by the manufacturer. Densitometric analysis revealed an F-actin:total actin 
(F:T) ratio of ~0.3, which is in the anticipated range. It was then speculated that epithelial cells 
may have a lower amount of actin or a lower F:T actin ratio and other epithelial cell lines were 
assessed. PVD9902 cells, which were derived from pig vas deferens and which exhibited an 
increase in transcellular conductance and paracellular permeation after apical NC-1059 exposure 
(Somasekharan et al., 2008) exhibited the highest F:T actin ratio of three epithelial cell types 
tested (Fig. 7; T84 cells revealed the lowest F:T actin ratio in basal conditions, ~5%, and were 
not used further). In basal conditions, the F:T actin ratio for PVD9902 cells was 16% and 
following exposure to NC-1059, the F:T actin ratio was reduced to 8%. After 48 hrs (the only 
time-point tested), the F:T actin ratio was indistinguishable from vehicle-treated monolayers. 
The results with PVD9902 cells are consistent with the outcomes shown in Fig. 6 for MDCK 
cells insofar as the amount of F-actin detectable after 60 min exposure to NC-1059 is extremely 
low and clearly reduced from pretreatment levels. The results with PVD9902 cells and T84 cells 
support the validity of the initial observations with MDCK cells showing very low F:T actin 
ratios in basal conditions. The ratio was reduced from 9.2±1.8% to 2.9±0.7% by NC-1059 
exposure (Fig. 7). Like PVD9902 cells, the F:T actin ratio in MDCK cells returned to 
pretreatment levels within 48 hrs. Taken together, the results presented in Figs 3.6 and 3.7 show 
that NC-1059 causes rapid and substantial changes in the actin cytoskeleton. These changes are 
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observable in the same time-frame as changes in Rte and may be associated with changes in tight 
junction architecture. 
 
Figure 3.7 NC-1059 decreases the F-actin ratio in both MDCK cells (A) and PVD9902 cells (B). 
Monolayers were exposed apically to vehicle or NC-1059 (200 µM) for 60 min and lysed immediately or 
the apical medium was refreshed and the cells were allowed to recover for 24 hr prior to cell lysis and 
analysis. Immunoreactivity of G-actin (G) and F-actin (F) was determined by densitometry as described 
in the text. Data are presented as F-actin to total actin ratio expressed as a percent. Results are 
summarized from n=4 for each cell type. Asterisk (*) indicates significant difference from vehicle. 
 
NC-1059 alters the distribution of occludin and ZO-1. 
NC-1059 exposure was associated with diminished immunoreactivity for the junctional 
proteins ZO-1 and occludin, with a more pronounced effect on ZO-1 (Fig 3.8A). Monolayers that 
were exposed to vehicle and labeled with anti-ZO-1 (red) and anti-occludin (green) antibodies 
showed strong immunoreactivity in the apical region of the MDCK monolayers. ZO-1 and 
occludin immunoreactivity localized at the tight junctions along cell-cell contact regions, as 
expected, and the epitopes appeared to colocalize, as shown in the merged image. Exposure of 
MDCK monolayers to NC-1059 (200 μM) for 5 min and 15 min showed apparent reductions in 
the intensity of labeling relative to vehicle treated monolayers. A pronounced reduction in ZO-1 
immunoreactivity was observed within 30 min of exposure. After 30 min of exposure there was 
not only a reduction in intensity of ZO-1 labeling, but there appeared to be an absence of labeling 
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in several areas of the monolayer. Occludin immunoreactivity appeared to be slightly reduced in 
intensity, albeit to a less pronounced extent when compared to ZO-1. After 60 min of NC-1059 
exposure, immunoreactivity to ZO-1 was negligible and the labeling for occludin appeared to be 
discontinuous with a pronounced reduction in intensity. Immunoreactivity to anti-occludin and 
anti-ZO-1 antibodies in monolayers that were exposed to NC-1074 for 30 min was comparable to 
vehicle. 
The decrease in immunoreactivity of the junctional proteins followed a concentration 
dependent pattern in MDCK monolayers (Fig 3.8B). Monolayers that were vehicle treated for 30 
or 60 min showed comparable patterns for both occludin and ZO-1 immunoreactivity. Exposure 
to 200 μM NC-1059 resulted in substantially diminished immunoreactivity for ZO-1 within 30 
min. Monolayers exposed to 100 μM NC-1059 for 30 min showed immunolabeling for both ZO-
1 and occludin comparable to a monolayer that was exposed only to vehicle for 30 min. After 60 
min of exposure, both 100 and 200 μM NC-1059 showed a pronounced decrease in ZO-1 
immunoreactivity and a discontinuous pattern of occludin immunoreactivity. The immunolabeled 
images suggested a concentration dependent effect on the localization or abundance of the 
junctional proteins occludin and ZO-1. 
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Figure 3.8 NC-1059 decreases ZO-1 and occludin immunoreactivity as a function of time and 
concentration. 
A) Time course of the effects of NC-1059 on ZO-1 and occludin localization. Monolayers exposed to 
Ringer solution only for 30 min or to Ringer solution and 200 μM NC-1059 for 5, 15, 30 or 60 min were 
labeled with anti-ZO-1 (red, top panel) and anti-occludin antibodies (green, middle panel). NC-1074 is a 
peptide that has no effect on transepithelial resistance and is used as a negative control. The bottom panels 
show the merged image with labeling for the nucleus in blue. B) Concentration dependent effects of NC-
1059 on ZO-1 and occludin localization. Monolayers were exposed to vehicle or exposed to 100 or 200 
μM NC-1059 for 30 or 60 min and subsequently labeled with anti-ZO-1 and anti-occludin antibodies, as 
indicated. All images were obtained as Z-stacks using confocal microscopy. Images shown are the 3-D 
projection of the respective Z-stacks. Results are a typical representation of n=4 and results presented 
represent data from paired monolayers processed in parallel. 
 
NC-1059 decreases the occludin and ZO-1 cellular abundance in a concentration dependent 
manner. 
 Immunoblotting was used to quantify the effect of 100 and 200 μM NC-1059 on the 
apparent abundance of occludin and ZO-1. Fig 3.9A is a typical immunoblot of protein extracted 
after apical exposure to 100 or 200 μM NC-1059 or vehicle for 30 or 60 min and labeled with 
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anti-ZO-1 antibodies. With 60 min exposure to NC-1059 there is an obvious decrease in labeling 
intensity. The average ZO-1 intensities normalized to GAPDH, which was used as a loading 
control, are presented in Fig 3.9B. The results suggested a concentration dependent decrease in 
ZO-1 immunoreactivity after 30 min that was reduced further and achieved statistical 
significance after 60 min of NC-1059 exposure. The intensities of vehicle exposed ZO-1 bands 
were comparable after 30 and 60 min.  
 
Figure 3.9 NC-1059 decreases cellular abundance of ZO-1 in a time and concentration dependent 
manner. 
A) Typical blot showing ZO-1 immunoreactivity in monolayers that were exposed either to vehicle or 
NC-1059 at the indicated concentrations and durations. B) Average ZO-1 immunoreactivity determined 
by densitometry and normalized to intensity of the corresponding GAPDH immunoreactivity, then 
normalized to vehicle, which is treated as 100%. Results are summarized from n=5. Asterisk (*) indicates 
significant difference from vehicle. 
 
Occludin immunoreactivity is also reduced by NC-1059 exposure. A typical immunoblot 
(Fig 3.10A) reveals a clear decrease in occludin immunoreactivity after 60 minutes of exposure 
to 100 and 200 μM NC-1059 relative to monolayers exposed to vehicle only for the same period 
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of time. The summarized results (Fig 3.10B) show decrease in the occludin immunoreactivity, 
after 30 min of exposure to 100 or 200 μM NC-1059, which is reduced further after 60 min. The 
results show both time- and concentration-dependent changes in cellular occludin abundance 
after exposure to NC-1059. 
 
Figure 3.10 NC-1059 decreases cellular abundance of occludin in a time and concentration 
dependent manner. 
A) Typical blot showing occludin immunoreactivity in monolayers that were exposed either to vehicle or 
NC-1059 at the indicated concentrations and durations. B) Average occludin immunoreactivity 
determined by densitometry and normalized to intensity of the corresponding GAPDH immunoreactivity, 
then normalized to vehicle, which is treated as 100%. Results are summarized from n=6. Asterisk (*) 
indicates significant difference from vehicle. 
 
Monolayers recover localization of tight junction proteins. 
Occludin and ZO-1 are localized at the tight junctions within 24 hr following exposure to 
NC-1059. The localization pattern after 48 hr is indistinguishable from vehicle treated 
monolayers (Fig 3.11). MDCK monolayers that were exposed to vehicle show that occludin and 
ZO-1 are localized as expected along the apical region of cell-cell contacts. MDCK monolayers 
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that were exposed to 200 μM NC-1059 for 1 hr exhibited little ZO-1 and occludin 
immunoreactivity along the expected apical cell-cell contacts contact points. NC-1059 treated 
monolayers that were recovered for 24 hrs showed anti-ZO-1 labeling at the tight junctions, 
similar to vehicle treated conditions. The intensity of occludin labeling was also recovered as 
compared to treatment with NC-1059 for 1 hr but appeared to be less pronounced as compared to 
the vehicle exposed monolayers. After 48 hr, ZO-1 immunolabeling showed a pattern and 
intensity comparable to control conditions, which suggests that localization of ZO-1 to the tight 
junctions was fully restored. Occludin localization along cell-cell contacts also appeared to be 
more pronounced after 48 hr of recovery. 
 
Figure 3.11 Occludin and ZO-1 immunoreactivities are again localized at all expected locations of 
tight junctions within 24 hrs following NC-1059 exposure.  
MDCK monolayers were exposed apically to vehicle or NC-1059 (200 μM) for 1 hr after which the 
monolayers were either fixed or transferred to fresh culture medium and returned to the incubator for 24 
or 48 hr before being fixed. Monolayers were then labeled with anti-occludin (green) and anti-ZO-1 (red) 
antibodies. Images were obtained as Z-stacks using confocal microscopy. Images shown are the 3-D 
projection of the respective Z-stacks. Results are a typical representation from n=2 for each condition. 
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NC-1059 alters the distribution and abundance of E-cadherin and β-catenin. 
NC-1059 caused a decrease in immunoreactivity of the adheren junction proteins E-
cadherin and β-catenin (Fig 3.12). Monolayers were exposed to 200 μM NC-1059 or vehicle for 
30 or 60 minutes. Monolayers were subsequently fixed and labeled with anti-E-cadherin and 
anti-β-catenin antibodies. An orthogonal view showing the central optical slice (0.8 μM) and 
labeling along the x and y axis is presented for each condition. Monolayers that were vehicle 
treated for 30 or 60 minutes showed a reticular pattern of labeling along cell-cell contacts for E-
cadherin and β-catenin, which is consistent with the localization of these proteins at the adheren 
junction. Exposure to 200 μM NC-1059 for 30 min resulted in decreased immunoreactivity of 
both E-cadherin and β-catenin and the labeling pattern appeared to be diffuse. After 60 minutes 
of exposure to 200 μM NC-1059, immunoreactivity of E-cadherin and β-catenin was diminished 
further. 
 
Figure 3.12 NC-1059 alters distribution of E-cadherin and β-catenin. 
Monolayers were exposed to 200µM NC-1059 or vehicle (Ringer solution) for 30 or 60 minutes and 
labeled with anti-E-cadherin (red, top panel) and anti-β-catenin (red, bottom panel) antibodies. Images are 
presented as an orthogonal view showing a single optical slice (0.8µM) of the Z-stack and the labeling 
along x and y axis. Results are a typical representation from n=2 for each condition. 
 
NC-1059 also reduced the cellular abundance of junctional proteins E-cadherin and β-
catenin. Typical immunoblots of monolayers exposed to vehicle, 100 and 200 μM NC-1059 for 
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30 or 60 minutes and immunolabeled for E-cadherin and β-catenin, are represented in Figs 3.13 
and 3.14, respectively.  
Concentration-dependent reduction in intensity of the E-cadherin immunoreactivity after 
exposure to 100 and 200 μM NC-1059 is observed after 60 min (Fig 3.13), although only a trend 
is apparent after 30 minutes of NC-1059 exposure. A faint immunoreactive band is observed at 
~80 kDa when monolayers are exposed to 200 µM NC-1059 for 60 min, which might represent a 
breakdown product of E-cadherin. 
 
Figure 3.13 NC-1059 affects cellular abundance of E-cadherin in a time and concentration 
dependent manner. 
A) Typical blot showing E-cadherin immunoreactivity in monolayers that were exposed either to vehicle 
or NC-1059 at the indicated concentrations and durations. B) Average E-cadherin immunoreactivity 
determined by densitometry and normalized to intensity of the corresponding GAPDH immunoreactivity, 
then normalized to vehicle, which is treated as 100%. Results are summarized from n=5. Asterisk (*) 
indicates significant difference from vehicle. 
 
The effect of NC-1059 on cellular abundance of β-catenin (Fig 3.14) is modest compared 
with other junctional proteins. Although there is only modest decrease in β-catenin abundance 
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after exposure to 100 µM NC-1059 and 200 µM NC-1059 for 30 minutes, exposure to NC-1059 
of 200 µM for 60 minutes resulted in a significantly decrease in immunoreactivity. The outcome 
suggests that NC-1059 affects adherens junction proteins as well as tight junction proteins in a 
concentration- and time- dependent trend.  
 
Figure 3.14 NC-1059 affects cellular abundance of β-catenin only at the highest concentration 
employed. 
A) Typical blot showing β-catenin immunoreactivity in monolayers that were exposed either to vehicle or 
NC-1059 at the indicated concentrations and durations. B) Average β-catenin immunoreactivity 
determined by densitometry and normalized to intensity of the corresponding GAPDH immunoreactivity, 
then normalized to vehicle, which is treated as 100%. Results are summarized from n=5. Asterisk (*) 
indicates significant difference from vehicle. 
 
 
 
 
 
 65 
Discussion 
The results demonstrate that NC-1059 induces an increase in paracellular permeability 
that is associated with a change in organization of the actin cytoskeleton and a decrease in 
abundance of occludin and ZO-1 at the tight junctions. Proteins associated with the adherens 
junctions are similarly affected in that the organization and abundance of both E-cadherin and β-
catenin are reduced. NC-1059 enhances gte and solute permeability through a paracellular route 
in MDCK monolayers in a time- and concentration-dependent manner. The effects of NC-1059 
on gte and localization or abundance of the junctional proteins are transient insofar as the gte and 
localization of tight junction proteins showed substantial recovery within 24 hr and complete 
recovery in 48 hr. 
Apical exposure to NC-1059 caused a large increase in gte in a concentration dependent 
manner. The rate of change in gte and maximal gte were significantly greater with 200 μM NC-
1059 compared to 100 μM NC-1059. Previous studies showed that 60 μM NC-1059 enhanced 
permeability to dextran although no enhancement in the passage of dextrans as large as 77 kDa 
was observed (Broughman et al., 2004). Current results, however, show that 200 μM NC-1059, a 
concentration that is greater than previously tested, enhanced the permeation of both 40 and 70 
kDa dextran several fold as compared to untreated monolayers. Permeation across epithelial 
barriers is the rate limiting step in the delivery of many drugs and since NC-1059 can enhance 
permeation of molecules as large as 70 kDa, it might provide the opportunity to be developed a 
co-therapeutic to enhance localized delivery of large molecular weight compounds that could be 
therapeutic if bioavailability issues can be overcome (e.g., interfering RNAs and antiviral drugs). 
Apical exposure to 200 μM NC-1059 caused a reorganization of actin that was detectable 
as early as 15 min after exposure. There was a pronounced decrease in the intensity of labeling of 
F-actin by phalloidin after 30 min of NC-1059 exposure. Actin reorganization following 
exposure to both 100 and 200 μM NC-1059 exhibited a similar time course. F-actin is the 
polymerized form of actin and G-actin is the monomeric form. The polymerization is a reversible 
reaction and the two forms exist in equilibrium (Lodish et al., 1995). Loss of phalloidin labeling 
of F-actin filaments and decrease in F:T ratio suggests that there is an NC-1059 induced 
depolymerization of F-actin. This could be due to an increase in the rate of depolymerization or 
destabilization of the F-actin structure as is the case with compounds such as cytochalasin 
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(Lodish et al., 1995). Based on observations under physiological conditions, it was proposed that 
the contraction of the perijunctional actomyosin ring might play a role in enhancing permeability 
through the paracellular route (Lodish et al., 1995; Turner et al., 1997). Extracellular molecules 
such as cytochalasins (Madara, Barenberg & Carlson, 1986), protamines (Peixoto & Collares-
Buzato, 2005) and ZOT (Fasano et al., 1995) are among several molecules that have been 
observed to enhance permeability by altering the organization of actin and specifically the 
perijunctional actomyosin ring. The NC-1059 induced increase in gte is associated with actin 
rearrangement, which might be a common mechanism associated with increase in paracellular 
permeability. 
NC-1059 treated MDCK monolayers show reduced immunoreactivity to antibodies 
against occludin and ZO-1, which suggests that NC-1059 causes a change in the distribution or 
abundance of these tight junction proteins. The distribution of ZO-1 appears to be altered to 
larger extent by 200 μM NC-1059 than by 100 μM at the 30 minute time point. Immunoblot 
analysis indicates NC-1059 decreases both occludin and ZO-1 abundance, which likely reflects 
enhanced breakdown of the junctional proteins, although the data do not rule out the possibility 
of an effect on synthesis. The loss of ZO-1, as indicated by immunoblotting also follows a 
concentration dependent trend. ZO-1 is a MAGUK protein that has several protein-protein 
interaction domains and hence serves as a scaffold for the interaction of junctional proteins and 
the actin cytoskeleton (Fanning et al., 1998; Funke, Dakoji & Bredt, 2005). ZO-1 interacts with 
occludin through its GUK domain and with actin through its C-terminus (Furuse et al., 1994; Li 
et al., 2005). Additionally occludin interacts with actin directly (Paris et al., 2008). Hence, the 
NC-1059 mediated change in actin organization might cause the loss of localization of occludin 
and ZO-1 at the tight junctions through its direct and indirect interactions with these proteins, 
ultimately leading to the disruption of barrier integrity.  
NC-1059 also affects the distribution and cellular abundance of the adheren junction 
proteins, E-cadherin and, to a lesser extent, β-catenin. The immunoblot for E-cadherin shows the 
appearance of an immunoreactive band with greater mobility, perhaps suggesting that E-cadherin 
is cleaved by a specific protease. Breakdown of E-cadherin has been reported in the case of ATP 
depletion (Bush, Tsukamoto & Nigam, 2000) and also implicated in the effects on paracellular 
permeability by the zinc metalloprotease, Bacteroides fragilis toxin (Richard et al., 1999; Wu et 
al., 1998). The detection of an 80 kDa fragment is unusual since metalloproteases cause 
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ectodomain shedding with loss of the 80 kDa fragment and detection of only a 30-40 kDa 
fragment in other systems (Wu et al., 2007). Nevertheless the results are consistent with a 
protease activity. The intensity of β-catenin localized at the adherens junctions is also 
diminished, but the effect of NC-1059 on overall abundance is modest. Only at the highest 
concentration and longest duration of exposure was a significant effect observed. The relatively 
modest effect on abundance might reflect the multiple roles of β-catenin in the cell. β-catenin not 
only plays a central function in bridging cadherins to actins in adheren junctions, but also is a 
key mediator of the Wnt-signaling pathway. Thus the total amount of β-catenin is highly 
controlled and changes in the amount associated with adherens junctions maybe difficult to 
detect on the cytosolic background. 
The effect of NC-1059 is transient. Despite the apparent reduction in F-actin, especially 
in the basal region of the cells, the monolayers remained adherent and gte recovered to 
pretreatment levels within 48 hours, with greater than 85% of the recovery in the first 24 hours. 
Within 24 hrs there was obvious recovery of ZO-1 localization to the cell periphery in the 
monolayers and occludin also recovered, although to a lesser extent. Recovery could involve 
either synthesis of new protein or recruitment from a preexisting or recycling pool. The reduction 
in overall immunoreactivity in Western blots argues against recycling of protein. Moreover the 
recovery in gte to pretreatment values requires more than 24 hours, which suggest that recovery 
might require synthesis and assembly of the junctional proteins. Localization of junctional 
proteins after 48 hrs is comparable to untreated monolayers. ZO-1 is proposed to be an early 
player in the assembly of junctional proteins (McNeil, Capaldo & Macara, 2006). Hence 
recovery in ZO-1 might be significant in the recovery of gte.  
The transient effect of NC-1059 on barrier function is particularly significant in 
developing a co-therapeutic to enhance delivery of drugs across epithelial barriers. ‗Absorption 
enhancers‘ are being developed to deliver clinically relevant therapeutics across epithelial 
barriers. Molecules that are hydrophilic and/or large cannot easily permeate epithelial barriers. 
Systemic drug delivery requires larger doses of drugs and is therefore associated with potential 
side effects (Torchilin, 2000). Several barrier epithelia such as intestinal, airway and 
corneal/conjuctival epithelia are potential targets for localized drug delivery (Edward & 
Prausnitz, 2001; Ghandehari et al., 1997). Results presented in this paper show that NC-1059 
enhances the permeation of molecules as large as 70 kDa across MDCK epithelial monolayers. 
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The effects on permeability can be generalized to several other epithelial cell lines derived from 
a variety of sources (Martin et al., 2009; Somasekharan et al., 2008).  
In summary, NC-1059 is a channel-forming peptide that reversibly modulates epithelial 
conductance and enhances permeability through the paracellular pathway. This may be caused 
by the reversibly altered organization of actin and localization of junctional proteins. Additional 
studies are required to determine the signaling pathways that link NC-1059 exposure to transient 
changes in the paracellular pathway. 
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